Correlation between copy number variation genes (focal events) and selected clinical features

Uterine Corpus Endometrioid Carcinoma (Primary solid tumor)

21 August 2015 | analyses__2015_08_21

Maintainer Information

Citation Information

Maintained by TCGA GDAC Team (Broad Institute/MD Anderson Cancer Center/Harvard Medical School)

Cite as Broad Institute TCGA Genome Data Analysis Center (2015): Correlation between copy number variation genes (focal events) and selected clinical features. Broad Institute of MIT and Harvard. doi:10.7908/C18K78DR

Overview

Introduction

This pipeline computes the correlation between significant copy number variation (cnv focal) genes and selected clinical features.

Summary

Testing the association between copy number variation 100 focal events and 7 clinical features across 536 patients, 406 significant findings detected with Q value < 0.25.

amp_1p35.2 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
amp_1p34.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
amp_1p22.3 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'ETHNICITY'.
amp_1q21.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_1q22 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_1q44 cnv correlated to 'YEARS_TO_BIRTH' and 'ETHNICITY'.
amp_2p24.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
amp_2q13 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.
amp_3p25.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_3p14.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RACE', and 'ETHNICITY'.
amp_3q26.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_3q26.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_4p16.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
amp_5p15.33 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_5q35.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_6p24.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
amp_6p22.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_6q25.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
amp_7q31.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
amp_8p11.22 cnv correlated to 'Time to Death'.
amp_8p11.21 cnv correlated to 'Time to Death', 'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.
amp_8q24.21 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
amp_8q24.21 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.
amp_9p24.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'ETHNICITY'.
amp_9q34.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_10q22.2 cnv correlated to 'Time to Death' and 'HISTOLOGICAL_TYPE'.
amp_11p11.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
amp_11q13.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.
amp_11q14.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
amp_12p12.1 cnv correlated to 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RACE', and 'ETHNICITY'.
amp_12q13.11 cnv correlated to 'HISTOLOGICAL_TYPE' and 'RACE'.
amp_12q13.2 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
amp_13q34 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
amp_14q24.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
amp_14q32.33 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_15q26.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.
amp_16p11.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.
amp_17q11.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
amp_17q12 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_17q25.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
amp_18p11.31 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
amp_18q11.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
amp_19p13.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_19q12 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
amp_20p13 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
amp_20q11.21 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
amp_20q13.12 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
amp_20q13.33 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
amp_22q12.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
amp_xp11.23 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
amp_xq28 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
del_1p36.21 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
del_1p36.11 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.
del_2p25.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.
del_2q22.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
del_2q37.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.
del_3p14.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RACE', and 'ETHNICITY'.
del_3q13.31 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
del_4p16.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
del_4p15.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
del_4q22.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.
del_4q34.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
del_5q12.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'HISTOLOGICAL_TYPE', 'RACE', and 'ETHNICITY'.
del_6q26 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', and 'HISTOLOGICAL_TYPE'.
del_7p22.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.
del_7q11.22 cnv correlated to 'YEARS_TO_BIRTH' and 'HISTOLOGICAL_TYPE'.
del_7q31.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
del_7q36.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
del_8p23.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
del_8p21.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
del_9p23 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
del_9q21.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
del_9q34.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.
del_10q23.31 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
del_11p15.5 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
del_11q14.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RACE', and 'ETHNICITY'.
del_11q25 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
del_12q23.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
del_12q24.33 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.
del_13q11 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
del_13q14.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
del_14q13.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RACE', and 'ETHNICITY'.
del_15q15.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
del_15q23 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
del_16p13.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
del_16q21 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
del_16q22.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
del_16q23.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
del_17p13.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
del_17p11.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', and 'RACE'.
del_17q11.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', and 'HISTOLOGICAL_TYPE'.
del_17q21.31 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'ETHNICITY'.
del_18q21.2 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
del_18q23 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', 'RACE', and 'ETHNICITY'.
del_19p13.3 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.
del_19p12 cnv correlated to 'YEARS_TO_BIRTH', 'RADIATION_THERAPY', 'HISTOLOGICAL_TYPE', and 'RESIDUAL_TUMOR'.
del_19q13.43 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'ETHNICITY'.
del_20p12.1 cnv correlated to 'Time to Death', 'HISTOLOGICAL_TYPE', and 'ETHNICITY'.
del_22q13.32 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', 'RACE', and 'ETHNICITY'.
del_xp21.1 cnv correlated to 'Time to Death', 'YEARS_TO_BIRTH', 'HISTOLOGICAL_TYPE', 'RESIDUAL_TUMOR', and 'RACE'.

Results

Overview of the results

Table 1. Get Full Table Overview of the association between significant copy number variation of 100 focal events and 7 clinical features. Shown in the table are P values (Q values). Thresholded by Q value < 0.25, 406 significant findings detected.


		Clinical Features	Time to Death	YEARS TO BIRTH	RADIATION THERAPY	HISTOLOGICAL TYPE	RESIDUAL TUMOR	RACE	ETHNICITY
	nCNV (%)	nWild-Type	logrank test	Wilcoxon-test	Fisher's exact test	Fisher's exact test	Fisher's exact test	Fisher's exact test	Fisher's exact test
del 18q23	97 (18%)	439	0.00053 (0.0019)	0.000613 (0.00212)	0.143 (0.247)	1e-05 (5.47e-05)	0.0102 (0.0257)	0.119 (0.216)	0.0415 (0.089)
amp 13q34	58 (11%)	478	0.0863 (0.164)	0.000103 (0.000445)	0.00395 (0.0112)	1e-05 (5.47e-05)	0.0133 (0.032)	0.104 (0.192)	1 (1.00)
amp 18q11 2	69 (13%)	467	0.0215 (0.0488)	0.000936 (0.00309)	0.14 (0.244)	1e-05 (5.47e-05)	0.0447 (0.0954)	0.0118 (0.0289)	1 (1.00)
del 5q12 1	111 (21%)	425	0.00106 (0.00339)	3.34e-06 (5.47e-05)	0.092 (0.174)	1e-05 (5.47e-05)	0.388 (0.529)	0.134 (0.237)	0.102 (0.189)
del 22q13 32	140 (26%)	396	0.000171 (0.000695)	4.77e-08 (1.96e-06)	0.754 (0.853)	1e-05 (5.47e-05)	0.141 (0.245)	0.0234 (0.0528)	0.138 (0.241)
amp 1p34 2	73 (14%)	463	0.000547 (0.00195)	0.000106 (0.000457)	0.514 (0.646)	1e-05 (5.47e-05)	0.108 (0.199)	0.0495 (0.104)	1 (1.00)
amp 3p14 1	64 (12%)	472	0.000735 (0.00246)	0.00429 (0.0121)	1 (1.00)	2e-05 (0.000108)	0.221 (0.346)	0.0153 (0.0363)	0.0298 (0.0657)
amp 3q26 2	174 (32%)	362	5.62e-05 (0.000268)	1.48e-11 (1.04e-08)	0.0328 (0.0713)	1e-05 (5.47e-05)	0.256 (0.391)	9e-05 (0.000396)	0.403 (0.544)
amp 3q26 2	163 (30%)	373	0.00029 (0.0011)	1.31e-09 (1.53e-07)	0.0487 (0.102)	1e-05 (5.47e-05)	0.173 (0.285)	0.00019 (0.00076)	0.165 (0.275)
amp 6q25 1	87 (16%)	449	0.0349 (0.0757)	0.000802 (0.00266)	0.902 (0.96)	1e-05 (5.47e-05)	0.0648 (0.131)	0.00537 (0.0146)	0.485 (0.623)
amp 11q14 1	58 (11%)	478	4.42e-06 (5.47e-05)	0.00721 (0.019)	0.884 (0.947)	1e-05 (5.47e-05)	0.115 (0.209)	0.122 (0.22)	1 (1.00)
amp 15q26 3	37 (7%)	499	0.00787 (0.0205)	0.00309 (0.00894)	0.0774 (0.151)	9e-05 (0.000396)	0.0116 (0.0284)	0.811 (0.891)	0.371 (0.516)
amp 17q11 2	71 (13%)	465	3.81e-05 (0.000198)	0.00519 (0.0142)	0.894 (0.953)	1e-05 (5.47e-05)	0.00106 (0.00339)	0.00395 (0.0112)	0.418 (0.556)
amp 17q25 1	104 (19%)	432	5.98e-06 (5.47e-05)	0.00146 (0.00451)	0.49 (0.624)	1e-05 (5.47e-05)	0.125 (0.224)	0.0001 (0.000435)	0.322 (0.46)
amp 18p11 31	96 (18%)	440	0.0119 (0.0289)	4.7e-05 (0.000235)	0.723 (0.828)	1e-05 (5.47e-05)	0.0253 (0.0569)	0.00428 (0.0121)	0.744 (0.846)
amp 19q12	120 (22%)	416	6.05e-06 (5.47e-05)	6.64e-09 (4.5e-07)	0.149 (0.256)	1e-05 (5.47e-05)	0.112 (0.205)	1e-05 (5.47e-05)	1 (1.00)
amp 20q11 21	151 (28%)	385	2.69e-06 (5.47e-05)	9.13e-09 (5.33e-07)	0.611 (0.745)	1e-05 (5.47e-05)	0.0737 (0.145)	0.0158 (0.037)	0.559 (0.691)
amp 20q13 12	151 (28%)	385	0.000623 (0.00215)	6.59e-09 (4.5e-07)	1 (1.00)	1e-05 (5.47e-05)	0.0265 (0.0592)	0.0156 (0.0369)	0.38 (0.521)
amp 20q13 33	152 (28%)	384	0.00157 (0.00483)	1.75e-08 (8.17e-07)	0.31 (0.448)	1e-05 (5.47e-05)	0.00494 (0.0137)	0.0776 (0.151)	1 (1.00)
amp 22q12 2	62 (12%)	474	7.64e-05 (0.000349)	0.000511 (0.00184)	0.888 (0.949)	1e-05 (5.47e-05)	0.00214 (0.00635)	0.0386 (0.0832)	0.689 (0.8)
del 2q22 1	47 (9%)	489	2.27e-10 (5.29e-08)	0.00603 (0.0161)	0.195 (0.314)	1e-05 (5.47e-05)	0.00071 (0.00239)	0.112 (0.204)	1 (1.00)
del 3p14 2	79 (15%)	457	0.0217 (0.0492)	0.000663 (0.00225)	0.307 (0.446)	1e-05 (5.47e-05)	0.632 (0.76)	0.0365 (0.0789)	0.141 (0.245)
del 4q34 3	129 (24%)	407	0.000579 (0.00203)	3.28e-07 (1.28e-05)	0.671 (0.789)	1e-05 (5.47e-05)	0.133 (0.236)	0.0305 (0.067)	0.763 (0.856)
del 8p23 2	118 (22%)	418	5.01e-05 (0.00024)	7.95e-06 (5.47e-05)	0.376 (0.517)	1e-05 (5.47e-05)	0.0505 (0.105)	0.0086 (0.0222)	0.207 (0.328)
del 8p21 2	116 (22%)	420	0.00106 (0.00339)	8.97e-07 (2.86e-05)	0.437 (0.573)	1e-05 (5.47e-05)	0.135 (0.238)	0.0109 (0.0269)	0.747 (0.846)
del 9q21 2	129 (24%)	407	8.73e-05 (0.000392)	3.59e-10 (6.28e-08)	1 (1.00)	1e-05 (5.47e-05)	0.0872 (0.165)	0.0558 (0.115)	0.373 (0.516)
del 11p15 5	105 (20%)	431	0.00177 (0.0054)	4.71e-06 (5.47e-05)	0.637 (0.761)	1e-05 (5.47e-05)	0.05 (0.104)	0.0595 (0.121)	0.519 (0.651)
del 11q14 1	70 (13%)	466	0.0298 (0.0657)	0.000255 (0.000991)	0.349 (0.489)	1e-05 (5.47e-05)	0.635 (0.76)	0.115 (0.209)	0.0148 (0.0352)
del 12q23 1	56 (10%)	480	0.00111 (0.0035)	0.00192 (0.00578)	0.246 (0.378)	1e-05 (5.47e-05)	0.0105 (0.0263)	0.0741 (0.146)	0.645 (0.768)
del 14q13 1	72 (13%)	464	0.00524 (0.0143)	0.00433 (0.0122)	1 (1.00)	1e-05 (5.47e-05)	0.984 (1.00)	0.01 (0.0253)	0.128 (0.228)
del 15q15 1	139 (26%)	397	8.28e-05 (0.000374)	7.07e-09 (4.5e-07)	0.676 (0.792)	1e-05 (5.47e-05)	0.0306 (0.067)	0.078 (0.151)	1 (1.00)
del 16p13 3	92 (17%)	444	0.000147 (0.000611)	3.51e-06 (5.47e-05)	1 (1.00)	1e-05 (5.47e-05)	0.067 (0.135)	0.0611 (0.124)	1 (1.00)
del 16q22 3	158 (29%)	378	0.0092 (0.0235)	2.35e-09 (2.35e-07)	0.92 (0.974)	1e-05 (5.47e-05)	0.135 (0.238)	0.0468 (0.0991)	0.782 (0.871)
del 16q23 1	166 (31%)	370	0.000371 (0.00137)	3.52e-09 (3.08e-07)	1 (1.00)	1e-05 (5.47e-05)	0.011 (0.027)	0.00673 (0.0179)	1 (1.00)
del 17p13 3	121 (23%)	415	8.93e-06 (5.47e-05)	0.000296 (0.00111)	0.658 (0.778)	1e-05 (5.47e-05)	0.0971 (0.182)	0.00488 (0.0136)	0.757 (0.855)
del 17q21 31	113 (21%)	423	0.000181 (0.000728)	5.92e-06 (5.47e-05)	0.577 (0.708)	1e-05 (5.47e-05)	0.0299 (0.0659)	0.193 (0.312)	0.0973 (0.182)
del 18q21 2	90 (17%)	446	0.077 (0.151)	0.000345 (0.00128)	0.454 (0.591)	1e-05 (5.47e-05)	0.0714 (0.142)	0.0976 (0.182)	0.312 (0.45)
del 19p13 3	153 (29%)	383	3.5e-07 (1.29e-05)	8.99e-11 (3.15e-08)	0.417 (0.556)	1e-05 (5.47e-05)	0.0087 (0.0224)	0.0006 (0.00209)	0.15 (0.257)
del 19q13 43	67 (12%)	469	0.000694 (0.00235)	0.000173 (0.000699)	0.776 (0.866)	1e-05 (5.47e-05)	0.0154 (0.0363)	0.263 (0.396)	0.101 (0.188)
del xp21 1	87 (16%)	449	7.05e-06 (5.47e-05)	0.000153 (0.000631)	0.709 (0.815)	1e-05 (5.47e-05)	0.123 (0.222)	0.00535 (0.0146)	0.281 (0.416)
amp 1q21 3	241 (45%)	295	0.0241 (0.0542)	7.27e-06 (5.47e-05)	0.651 (0.774)	4e-05 (0.000204)	0.689 (0.8)	0.00545 (0.0147)	0.186 (0.302)
amp 1q22	255 (48%)	281	0.00236 (0.00691)	4.68e-08 (1.96e-06)	0.857 (0.932)	1e-05 (5.47e-05)	0.291 (0.428)	0.00945 (0.024)	0.295 (0.431)
amp 2q13	119 (22%)	417	3.11e-06 (5.47e-05)	0.000128 (0.000538)	0.13 (0.231)	1e-05 (5.47e-05)	0.219 (0.344)	0.274 (0.407)	1 (1.00)
amp 3p25 1	82 (15%)	454	0.0521 (0.107)	0.000228 (0.00089)	1 (1.00)	1e-05 (5.47e-05)	0.68 (0.795)	0.00342 (0.00985)	0.717 (0.823)
amp 5p15 33	89 (17%)	447	0.000108 (0.000462)	0.000117 (0.000494)	0.263 (0.396)	1e-05 (5.47e-05)	0.158 (0.267)	0.0058 (0.0156)	0.306 (0.445)
amp 5q35 3	57 (11%)	479	0.000627 (0.00215)	0.000166 (0.000678)	0.45 (0.587)	1e-05 (5.47e-05)	0.403 (0.544)	0.0197 (0.045)	0.233 (0.363)
amp 6p22 3	106 (20%)	430	0.0718 (0.142)	0.000269 (0.00104)	0.425 (0.559)	1e-05 (5.47e-05)	0.475 (0.616)	0.0174 (0.0403)	0.321 (0.459)
amp 8q24 21	214 (40%)	322	2.42e-05 (0.000129)	0.00703 (0.0186)	0.853 (0.929)	1e-05 (5.47e-05)	0.0125 (0.0301)	0.616 (0.749)	0.602 (0.736)
amp 9p24 2	64 (12%)	472	0.00505 (0.0139)	0.0017 (0.00521)	0.384 (0.524)	1e-05 (5.47e-05)	0.151 (0.258)	0.231 (0.36)	0.0274 (0.061)
amp 9q34 3	39 (7%)	497	0.046 (0.0978)	0.00103 (0.00335)	0.86 (0.933)	1e-05 (5.47e-05)	0.514 (0.646)	0.00707 (0.0187)	0.612 (0.745)
amp 11q13 2	73 (14%)	463	0.00222 (0.00655)	0.000278 (0.00107)	0.793 (0.881)	1e-05 (5.47e-05)	0.0606 (0.123)	0.626 (0.759)	0.704 (0.812)
amp 12p12 1	93 (17%)	443	0.696 (0.806)	0.095 (0.179)	0.19 (0.308)	1e-05 (5.47e-05)	0.758 (0.855)	0.144 (0.249)	0.0838 (0.16)
amp 14q32 33	79 (15%)	457	0.0037 (0.0106)	0.00132 (0.00413)	0.897 (0.956)	1e-05 (5.47e-05)	0.18 (0.294)	0.0183 (0.0422)	0.708 (0.815)
amp 16p11 2	66 (12%)	470	0.0474 (0.1)	0.000193 (0.000768)	0.682 (0.795)	1e-05 (5.47e-05)	0.0423 (0.0905)	0.157 (0.266)	1 (1.00)
amp 17q12	75 (14%)	461	7.16e-05 (0.000334)	0.0018 (0.00546)	0.292 (0.428)	1e-05 (5.47e-05)	0.258 (0.392)	0.00462 (0.0129)	1 (1.00)
amp 19p13 2	98 (18%)	438	0.0141 (0.0337)	5.58e-10 (7.81e-08)	0.197 (0.316)	1e-05 (5.47e-05)	0.276 (0.409)	0.00305 (0.00886)	0.746 (0.846)
amp 20p13	117 (22%)	419	0.071 (0.142)	2.74e-06 (5.47e-05)	0.826 (0.903)	1e-05 (5.47e-05)	0.48 (0.621)	0.077 (0.151)	0.325 (0.461)
del 1p36 11	82 (15%)	454	5.81e-05 (0.000275)	7.6e-05 (0.000349)	0.799 (0.886)	1e-05 (5.47e-05)	0.0579 (0.118)	0.42 (0.556)	0.266 (0.397)
del 2p25 3	26 (5%)	510	0.0148 (0.0352)	0.0671 (0.135)	0.13 (0.231)	0.0101 (0.0254)	0.324 (0.46)	0.469 (0.61)	1 (1.00)
del 2q37 3	52 (10%)	484	0.0814 (0.156)	0.00233 (0.00686)	0.88 (0.945)	5e-05 (0.00024)	0.0515 (0.106)	0.173 (0.285)	1 (1.00)
del 4q22 1	105 (20%)	431	0.000148 (0.000611)	5.72e-06 (5.47e-05)	0.645 (0.768)	1e-05 (5.47e-05)	0.0508 (0.106)	0.371 (0.516)	0.504 (0.636)
del 6q26	46 (9%)	490	0.137 (0.24)	0.0076 (0.0199)	0.0684 (0.137)	1e-05 (5.47e-05)	0.873 (0.945)	0.939 (0.991)	1 (1.00)
del 7p22 3	72 (13%)	464	0.00038 (0.00139)	3.85e-05 (0.000198)	0.423 (0.557)	1e-05 (5.47e-05)	0.0934 (0.176)	0.196 (0.315)	0.418 (0.556)
del 9q34 2	131 (24%)	405	3.31e-05 (0.000175)	1.7e-08 (8.17e-07)	0.4 (0.543)	1e-05 (5.47e-05)	0.0973 (0.182)	0.252 (0.385)	0.77 (0.861)
del 11q25	92 (17%)	444	0.000456 (0.00166)	0.000222 (0.000873)	0.81 (0.891)	1e-05 (5.47e-05)	0.38 (0.521)	0.127 (0.228)	0.737 (0.842)
del 12q24 33	65 (12%)	471	0.00445 (0.0125)	4.04e-05 (0.000205)	0.482 (0.621)	1e-05 (5.47e-05)	0.0189 (0.0435)	0.364 (0.509)	1 (1.00)
del 15q23	115 (21%)	421	0.0181 (0.0417)	6.34e-06 (5.47e-05)	0.263 (0.396)	1e-05 (5.47e-05)	0.489 (0.624)	0.0468 (0.0991)	0.538 (0.669)
del 16q21	153 (29%)	383	0.000561 (0.00198)	1.24e-08 (6.7e-07)	0.919 (0.974)	1e-05 (5.47e-05)	0.204 (0.325)	0.0322 (0.0703)	0.568 (0.699)
del 17p11 2	127 (24%)	409	4.16e-05 (0.000209)	1.67e-06 (5.09e-05)	0.914 (0.97)	1e-05 (5.47e-05)	0.266 (0.398)	0.0164 (0.0384)	0.761 (0.856)
del 19p12	58 (11%)	478	0.199 (0.318)	0.00728 (0.0191)	0.139 (0.243)	1e-05 (5.47e-05)	0.0812 (0.156)	0.159 (0.267)	0.672 (0.789)
amp 1p22 3	96 (18%)	440	0.494 (0.629)	0.00112 (0.00352)	1 (1.00)	0.00028 (0.00107)	0.933 (0.987)	0.339 (0.478)	0.0857 (0.163)
amp 2p24 3	120 (22%)	416	4.8e-05 (0.000238)	0.0108 (0.0268)	0.664 (0.782)	1e-05 (5.47e-05)	0.806 (0.891)	0.428 (0.562)	0.537 (0.669)
amp 4p16 3	53 (10%)	483	0.0611 (0.124)	1.66e-05 (9.02e-05)	0.368 (0.513)	1e-05 (5.47e-05)	0.168 (0.278)	0.483 (0.621)	0.636 (0.76)
amp 6p24 2	116 (22%)	420	0.0119 (0.0289)	3.75e-06 (5.47e-05)	1 (1.00)	1e-05 (5.47e-05)	0.655 (0.777)	0.239 (0.37)	0.745 (0.846)
amp 7q31 2	93 (17%)	443	4.83e-05 (0.000238)	0.0798 (0.154)	0.81 (0.891)	5e-05 (0.00024)	0.42 (0.556)	0.743 (0.846)	0.321 (0.459)
amp 8p11 21	162 (30%)	374	8.79e-05 (0.000392)	0.762 (0.856)	0.322 (0.459)	1e-05 (5.47e-05)	0.00539 (0.0146)	0.257 (0.391)	0.408 (0.55)
amp 8q24 21	208 (39%)	328	7.41e-05 (0.000344)	0.0211 (0.0481)	0.781 (0.87)	1e-05 (5.47e-05)	0.211 (0.334)	0.216 (0.341)	0.421 (0.556)
amp 11p11 2	51 (10%)	485	0.000577 (0.00203)	0.000293 (0.0011)	0.879 (0.945)	1e-05 (5.47e-05)	0.41 (0.55)	0.39 (0.53)	0.631 (0.76)
amp 14q24 3	64 (12%)	472	0.00207 (0.0062)	0.0021 (0.00628)	0.488 (0.624)	1e-05 (5.47e-05)	0.417 (0.556)	0.444 (0.581)	0.702 (0.81)
amp xq28	92 (17%)	444	0.0008 (0.00266)	0.0511 (0.106)	0.626 (0.759)	0.00032 (0.00119)	0.219 (0.344)	0.542 (0.672)	0.728 (0.832)
del 1p36 21	71 (13%)	465	0.0169 (0.0394)	0.000121 (0.000509)	0.688 (0.8)	1e-05 (5.47e-05)	0.633 (0.76)	0.26 (0.395)	0.413 (0.554)
del 4p16 3	93 (17%)	443	0.0108 (0.0268)	9.76e-05 (0.000427)	1 (1.00)	1e-05 (5.47e-05)	0.876 (0.945)	0.309 (0.448)	0.497 (0.631)
del 4p15 2	97 (18%)	439	0.00164 (0.00502)	3.76e-05 (0.000197)	0.635 (0.76)	1e-05 (5.47e-05)	0.341 (0.48)	0.376 (0.517)	0.177 (0.289)
del 7q31 1	54 (10%)	482	0.011 (0.027)	7.75e-05 (0.000352)	0.173 (0.285)	1e-05 (5.47e-05)	0.25 (0.384)	0.163 (0.272)	0.66 (0.78)
del 7q36 1	63 (12%)	473	0.0014 (0.00436)	4.8e-07 (1.68e-05)	0.263 (0.396)	1e-05 (5.47e-05)	0.282 (0.416)	0.512 (0.645)	0.702 (0.81)
del 9p23	79 (15%)	457	0.0083 (0.0215)	0.0011 (0.00349)	0.801 (0.887)	1e-05 (5.47e-05)	0.235 (0.365)	0.227 (0.354)	1 (1.00)
del 10q23 31	77 (14%)	459	0.000945 (0.00309)	0.000291 (0.0011)	1 (1.00)	1e-05 (5.47e-05)	0.176 (0.288)	0.288 (0.424)	1 (1.00)
del 13q11	97 (18%)	439	0.000943 (0.00309)	0.00113 (0.00355)	1 (1.00)	1e-05 (5.47e-05)	0.162 (0.27)	0.349 (0.489)	0.497 (0.631)
del 13q14 2	106 (20%)	430	0.000985 (0.00321)	0.000638 (0.00218)	0.354 (0.496)	1e-05 (5.47e-05)	0.318 (0.457)	0.162 (0.27)	0.331 (0.469)
del 17q11 2	104 (19%)	432	0.00928 (0.0236)	6.1e-07 (2.03e-05)	0.564 (0.695)	1e-05 (5.47e-05)	0.161 (0.27)	0.825 (0.903)	0.504 (0.636)
del 20p12 1	36 (7%)	500	6.68e-05 (0.000314)	0.157 (0.266)	0.588 (0.721)	5e-05 (0.00024)	0.154 (0.262)	0.264 (0.396)	0.11 (0.201)
amp 1p35 2	56 (10%)	480	0.238 (0.369)	0.000212 (0.000838)	0.88 (0.945)	1e-05 (5.47e-05)	0.335 (0.474)	0.245 (0.378)	0.184 (0.3)
amp 1q44	217 (40%)	319	0.257 (0.391)	0.00214 (0.00635)	0.521 (0.652)	0.403 (0.544)	0.373 (0.516)	0.166 (0.275)	0.11 (0.201)
amp 10q22 2	143 (27%)	393	0.0713 (0.142)	0.199 (0.318)	0.84 (0.916)	0.003 (0.00875)	0.388 (0.529)	0.556 (0.689)	0.768 (0.86)
amp 12q13 11	86 (16%)	450	0.678 (0.794)	0.53 (0.662)	0.206 (0.328)	1e-05 (5.47e-05)	0.273 (0.407)	0.0296 (0.0657)	0.482 (0.621)
amp 12q13 2	99 (18%)	437	0.559 (0.691)	0.0812 (0.156)	0.813 (0.893)	1e-05 (5.47e-05)	0.153 (0.261)	0.207 (0.328)	1 (1.00)
amp xp11 23	90 (17%)	446	0.157 (0.266)	0.0169 (0.0394)	0.808 (0.891)	0.00047 (0.0017)	0.42 (0.556)	0.973 (1.00)	0.486 (0.623)
del 3q13 31	43 (8%)	493	0.876 (0.945)	0.000552 (0.00196)	1 (1.00)	1e-05 (5.47e-05)	0.633 (0.76)	0.827 (0.903)	1 (1.00)
del 7q11 22	41 (8%)	495	0.982 (1.00)	3.32e-05 (0.000175)	0.867 (0.939)	1e-05 (5.47e-05)	0.473 (0.614)	0.533 (0.666)	0.312 (0.45)
amp 8p11 22	126 (24%)	410	0.00875 (0.0224)	0.304 (0.444)	0.595 (0.728)	0.885 (0.947)	0.657 (0.778)	0.293 (0.428)	0.376 (0.517)

'amp_1p35.2' versus 'YEARS_TO_BIRTH'

P value = 0.000212 (Wilcoxon-test), Q value = 0.00084

Table S1. Gene #1: 'amp_1p35.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 1(1P35.2) MUTATED	55	68.6 (8.8)
AMP PEAK 1(1P35.2) WILD-TYPE	479	63.5 (11.3)

Figure S1. Get High-res Image Gene #1: 'amp_1p35.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_1p35.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S2. Gene #1: 'amp_1p35.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 1(1P35.2) MUTATED	16	5	35
AMP PEAK 1(1P35.2) WILD-TYPE	385	17	78

Figure S2. Get High-res Image Gene #1: 'amp_1p35.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_1p34.2' versus 'Time to Death'

P value = 0.000547 (logrank test), Q value = 0.002

Table S3. Gene #2: 'amp_1p34.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 2(1P34.2) MUTATED	73	20	0.1 - 125.4 (22.6)
AMP PEAK 2(1P34.2) WILD-TYPE	461	61	0.0 - 225.5 (27.9)

Figure S3. Get High-res Image Gene #2: 'amp_1p34.2' versus Clinical Feature #1: 'Time to Death'

'amp_1p34.2' versus 'YEARS_TO_BIRTH'

P value = 0.000106 (Wilcoxon-test), Q value = 0.00046

Table S4. Gene #2: 'amp_1p34.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 2(1P34.2) MUTATED	72	68.5 (9.4)
AMP PEAK 2(1P34.2) WILD-TYPE	462	63.3 (11.3)

Figure S4. Get High-res Image Gene #2: 'amp_1p34.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_1p34.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S5. Gene #2: 'amp_1p34.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 2(1P34.2) MUTATED	21	7	45
AMP PEAK 2(1P34.2) WILD-TYPE	380	15	68

Figure S5. Get High-res Image Gene #2: 'amp_1p34.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_1p34.2' versus 'RESIDUAL_TUMOR'

P value = 0.108 (Fisher's exact test), Q value = 0.2

Table S6. Gene #2: 'amp_1p34.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
AMP PEAK 2(1P34.2) MUTATED	45	4	5	7
AMP PEAK 2(1P34.2) WILD-TYPE	325	18	12	30

Figure S6. Get High-res Image Gene #2: 'amp_1p34.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'amp_1p34.2' versus 'RACE'

P value = 0.0495 (Fisher's exact test), Q value = 0.1

Table S7. Gene #2: 'amp_1p34.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 2(1P34.2) MUTATED	0	1	22	2	40
AMP PEAK 2(1P34.2) WILD-TYPE	4	19	84	7	328

Figure S7. Get High-res Image Gene #2: 'amp_1p34.2' versus Clinical Feature #6: 'RACE'

'amp_1p22.3' versus 'YEARS_TO_BIRTH'

P value = 0.00112 (Wilcoxon-test), Q value = 0.0035

Table S8. Gene #3: 'amp_1p22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 3(1P22.3) MUTATED	96	67.2 (9.5)
AMP PEAK 3(1P22.3) WILD-TYPE	438	63.3 (11.4)

Figure S8. Get High-res Image Gene #3: 'amp_1p22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_1p22.3' versus 'HISTOLOGICAL_TYPE'

P value = 0.00028 (Fisher's exact test), Q value = 0.0011

Table S9. Gene #3: 'amp_1p22.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 3(1P22.3) MUTATED	56	5	35
AMP PEAK 3(1P22.3) WILD-TYPE	345	17	78

Figure S9. Get High-res Image Gene #3: 'amp_1p22.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_1p22.3' versus 'ETHNICITY'

P value = 0.0857 (Fisher's exact test), Q value = 0.16

Table S10. Gene #3: 'amp_1p22.3' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	15	372
AMP PEAK 3(1P22.3) MUTATED	0	65
AMP PEAK 3(1P22.3) WILD-TYPE	15	307

Figure S10. Get High-res Image Gene #3: 'amp_1p22.3' versus Clinical Feature #7: 'ETHNICITY'

'amp_1q21.3' versus 'Time to Death'

P value = 0.0241 (logrank test), Q value = 0.054

Table S11. Gene #4: 'amp_1q21.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 4(1Q21.3) MUTATED	240	45	0.1 - 149.6 (24.1)
AMP PEAK 4(1Q21.3) WILD-TYPE	294	36	0.0 - 225.5 (28.9)

Figure S11. Get High-res Image Gene #4: 'amp_1q21.3' versus Clinical Feature #1: 'Time to Death'

'amp_1q21.3' versus 'YEARS_TO_BIRTH'

P value = 7.27e-06 (Wilcoxon-test), Q value = 5.5e-05

Table S12. Gene #4: 'amp_1q21.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 4(1Q21.3) MUTATED	241	66.5 (10.3)
AMP PEAK 4(1Q21.3) WILD-TYPE	293	61.9 (11.5)

Figure S12. Get High-res Image Gene #4: 'amp_1q21.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_1q21.3' versus 'HISTOLOGICAL_TYPE'

P value = 4e-05 (Fisher's exact test), Q value = 2e-04

Table S13. Gene #4: 'amp_1q21.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 4(1Q21.3) MUTATED	158	10	73
AMP PEAK 4(1Q21.3) WILD-TYPE	243	12	40

Figure S13. Get High-res Image Gene #4: 'amp_1q21.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_1q21.3' versus 'RACE'

P value = 0.00545 (Fisher's exact test), Q value = 0.015

Table S14. Gene #4: 'amp_1q21.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 4(1Q21.3) MUTATED	2	5	62	2	157
AMP PEAK 4(1Q21.3) WILD-TYPE	2	15	44	7	211

Figure S14. Get High-res Image Gene #4: 'amp_1q21.3' versus Clinical Feature #6: 'RACE'

'amp_1q22' versus 'Time to Death'

P value = 0.00236 (logrank test), Q value = 0.0069

Table S15. Gene #5: 'amp_1q22' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 5(1Q22) MUTATED	255	50	0.1 - 149.6 (25.0)
AMP PEAK 5(1Q22) WILD-TYPE	279	31	0.0 - 225.5 (29.9)

Figure S15. Get High-res Image Gene #5: 'amp_1q22' versus Clinical Feature #1: 'Time to Death'

'amp_1q22' versus 'YEARS_TO_BIRTH'

P value = 4.68e-08 (Wilcoxon-test), Q value = 2e-06

Table S16. Gene #5: 'amp_1q22' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 5(1Q22) MUTATED	255	66.8 (10.4)
AMP PEAK 5(1Q22) WILD-TYPE	279	61.4 (11.3)

Figure S16. Get High-res Image Gene #5: 'amp_1q22' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_1q22' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S17. Gene #5: 'amp_1q22' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 5(1Q22) MUTATED	164	11	80
AMP PEAK 5(1Q22) WILD-TYPE	237	11	33

Figure S17. Get High-res Image Gene #5: 'amp_1q22' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_1q22' versus 'RACE'

P value = 0.00945 (Fisher's exact test), Q value = 0.024

Table S18. Gene #5: 'amp_1q22' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 5(1Q22) MUTATED	2	5	63	2	171
AMP PEAK 5(1Q22) WILD-TYPE	2	15	43	7	197

Figure S18. Get High-res Image Gene #5: 'amp_1q22' versus Clinical Feature #6: 'RACE'

'amp_1q44' versus 'YEARS_TO_BIRTH'

P value = 0.00214 (Wilcoxon-test), Q value = 0.0063

Table S19. Gene #6: 'amp_1q44' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 6(1Q44) MUTATED	217	65.9 (10.4)
AMP PEAK 6(1Q44) WILD-TYPE	317	62.7 (11.6)

Figure S19. Get High-res Image Gene #6: 'amp_1q44' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_1q44' versus 'ETHNICITY'

P value = 0.11 (Fisher's exact test), Q value = 0.2

Table S20. Gene #6: 'amp_1q44' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	15	372
AMP PEAK 6(1Q44) MUTATED	3	158
AMP PEAK 6(1Q44) WILD-TYPE	12	214

Figure S20. Get High-res Image Gene #6: 'amp_1q44' versus Clinical Feature #7: 'ETHNICITY'

'amp_2p24.3' versus 'Time to Death'

P value = 4.8e-05 (logrank test), Q value = 0.00024

Table S21. Gene #7: 'amp_2p24.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 7(2P24.3) MUTATED	119	31	0.1 - 149.6 (24.1)
AMP PEAK 7(2P24.3) WILD-TYPE	415	50	0.0 - 225.5 (27.9)

Figure S21. Get High-res Image Gene #7: 'amp_2p24.3' versus Clinical Feature #1: 'Time to Death'

'amp_2p24.3' versus 'YEARS_TO_BIRTH'

P value = 0.0108 (Wilcoxon-test), Q value = 0.027

Table S22. Gene #7: 'amp_2p24.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 7(2P24.3) MUTATED	119	66.2 (10.3)
AMP PEAK 7(2P24.3) WILD-TYPE	415	63.4 (11.4)

Figure S22. Get High-res Image Gene #7: 'amp_2p24.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_2p24.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S23. Gene #7: 'amp_2p24.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 7(2P24.3) MUTATED	54	8	58
AMP PEAK 7(2P24.3) WILD-TYPE	347	14	55

Figure S23. Get High-res Image Gene #7: 'amp_2p24.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_2q13' versus 'Time to Death'

P value = 3.11e-06 (logrank test), Q value = 5.5e-05

Table S24. Gene #8: 'amp_2q13' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 8(2Q13) MUTATED	118	34	0.3 - 149.6 (24.0)
AMP PEAK 8(2Q13) WILD-TYPE	416	47	0.0 - 225.5 (27.9)

Figure S24. Get High-res Image Gene #8: 'amp_2q13' versus Clinical Feature #1: 'Time to Death'

'amp_2q13' versus 'YEARS_TO_BIRTH'

P value = 0.000128 (Wilcoxon-test), Q value = 0.00054

Table S25. Gene #8: 'amp_2q13' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 8(2Q13) MUTATED	118	67.2 (9.1)
AMP PEAK 8(2Q13) WILD-TYPE	416	63.1 (11.6)

Figure S25. Get High-res Image Gene #8: 'amp_2q13' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_2q13' versus 'RADIATION_THERAPY'

P value = 0.13 (Fisher's exact test), Q value = 0.23

Table S26. Gene #8: 'amp_2q13' versus Clinical Feature #3: 'RADIATION_THERAPY'

nPatients	NO	YES
ALL	284	218
AMP PEAK 8(2Q13) MUTATED	56	56
AMP PEAK 8(2Q13) WILD-TYPE	228	162

Figure S26. Get High-res Image Gene #8: 'amp_2q13' versus Clinical Feature #3: 'RADIATION_THERAPY'

'amp_2q13' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S27. Gene #8: 'amp_2q13' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 8(2Q13) MUTATED	45	6	68
AMP PEAK 8(2Q13) WILD-TYPE	356	16	45

Figure S27. Get High-res Image Gene #8: 'amp_2q13' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_3p25.1' versus 'Time to Death'

P value = 0.0521 (logrank test), Q value = 0.11

Table S28. Gene #9: 'amp_3p25.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 9(3P25.1) MUTATED	82	20	0.1 - 225.5 (31.2)
AMP PEAK 9(3P25.1) WILD-TYPE	452	61	0.0 - 185.8 (27.2)

Figure S28. Get High-res Image Gene #9: 'amp_3p25.1' versus Clinical Feature #1: 'Time to Death'

'amp_3p25.1' versus 'YEARS_TO_BIRTH'

P value = 0.000228 (Wilcoxon-test), Q value = 0.00089

Table S29. Gene #9: 'amp_3p25.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 9(3P25.1) MUTATED	82	68.4 (10.5)
AMP PEAK 9(3P25.1) WILD-TYPE	452	63.2 (11.1)

Figure S29. Get High-res Image Gene #9: 'amp_3p25.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_3p25.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S30. Gene #9: 'amp_3p25.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 9(3P25.1) MUTATED	36	2	44
AMP PEAK 9(3P25.1) WILD-TYPE	365	20	69

Figure S30. Get High-res Image Gene #9: 'amp_3p25.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_3p25.1' versus 'RACE'

P value = 0.00342 (Fisher's exact test), Q value = 0.0099

Table S31. Gene #9: 'amp_3p25.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 9(3P25.1) MUTATED	0	0	24	4	48
AMP PEAK 9(3P25.1) WILD-TYPE	4	20	82	5	320

Figure S31. Get High-res Image Gene #9: 'amp_3p25.1' versus Clinical Feature #6: 'RACE'

'amp_3p14.1' versus 'Time to Death'

P value = 0.000735 (logrank test), Q value = 0.0025

Table S32. Gene #10: 'amp_3p14.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 10(3P14.1) MUTATED	64	20	0.1 - 225.5 (28.0)
AMP PEAK 10(3P14.1) WILD-TYPE	470	61	0.0 - 185.8 (27.3)

Figure S32. Get High-res Image Gene #10: 'amp_3p14.1' versus Clinical Feature #1: 'Time to Death'

'amp_3p14.1' versus 'YEARS_TO_BIRTH'

P value = 0.00429 (Wilcoxon-test), Q value = 0.012

Table S33. Gene #10: 'amp_3p14.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 10(3P14.1) MUTATED	64	68.0 (10.3)
AMP PEAK 10(3P14.1) WILD-TYPE	470	63.5 (11.2)

Figure S33. Get High-res Image Gene #10: 'amp_3p14.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_3p14.1' versus 'HISTOLOGICAL_TYPE'

P value = 2e-05 (Fisher's exact test), Q value = 0.00011

Table S34. Gene #10: 'amp_3p14.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 10(3P14.1) MUTATED	33	3	28
AMP PEAK 10(3P14.1) WILD-TYPE	368	19	85

Figure S34. Get High-res Image Gene #10: 'amp_3p14.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_3p14.1' versus 'RACE'

P value = 0.0153 (Fisher's exact test), Q value = 0.036

Table S35. Gene #10: 'amp_3p14.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 10(3P14.1) MUTATED	1	0	15	4	41
AMP PEAK 10(3P14.1) WILD-TYPE	3	20	91	5	327

Figure S35. Get High-res Image Gene #10: 'amp_3p14.1' versus Clinical Feature #6: 'RACE'

'amp_3p14.1' versus 'ETHNICITY'

P value = 0.0298 (Fisher's exact test), Q value = 0.066

Table S36. Gene #10: 'amp_3p14.1' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	15	372
AMP PEAK 10(3P14.1) MUTATED	5	44
AMP PEAK 10(3P14.1) WILD-TYPE	10	328

Figure S36. Get High-res Image Gene #10: 'amp_3p14.1' versus Clinical Feature #7: 'ETHNICITY'

'amp_3q26.2' versus 'Time to Death'

P value = 5.62e-05 (logrank test), Q value = 0.00027

Table S37. Gene #11: 'amp_3q26.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 11(3Q26.2) MUTATED	174	42	0.1 - 225.5 (27.2)
AMP PEAK 11(3Q26.2) WILD-TYPE	360	39	0.0 - 185.8 (27.9)

Figure S37. Get High-res Image Gene #11: 'amp_3q26.2' versus Clinical Feature #1: 'Time to Death'

'amp_3q26.2' versus 'YEARS_TO_BIRTH'

P value = 1.48e-11 (Wilcoxon-test), Q value = 1e-08

Table S38. Gene #11: 'amp_3q26.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 11(3Q26.2) MUTATED	173	68.4 (9.3)
AMP PEAK 11(3Q26.2) WILD-TYPE	361	61.9 (11.4)

Figure S38. Get High-res Image Gene #11: 'amp_3q26.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_3q26.2' versus 'RADIATION_THERAPY'

P value = 0.0328 (Fisher's exact test), Q value = 0.071

Table S39. Gene #11: 'amp_3q26.2' versus Clinical Feature #3: 'RADIATION_THERAPY'

nPatients	NO	YES
ALL	284	218
AMP PEAK 11(3Q26.2) MUTATED	78	80
AMP PEAK 11(3Q26.2) WILD-TYPE	206	138

Figure S39. Get High-res Image Gene #11: 'amp_3q26.2' versus Clinical Feature #3: 'RADIATION_THERAPY'

'amp_3q26.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S40. Gene #11: 'amp_3q26.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 11(3Q26.2) MUTATED	75	8	91
AMP PEAK 11(3Q26.2) WILD-TYPE	326	14	22

Figure S40. Get High-res Image Gene #11: 'amp_3q26.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_3q26.2' versus 'RACE'

P value = 9e-05 (Fisher's exact test), Q value = 4e-04

Table S41. Gene #11: 'amp_3q26.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 11(3Q26.2) MUTATED	0	3	52	4	101
AMP PEAK 11(3Q26.2) WILD-TYPE	4	17	54	5	267

Figure S41. Get High-res Image Gene #11: 'amp_3q26.2' versus Clinical Feature #6: 'RACE'

'amp_3q26.2' versus 'Time to Death'

P value = 0.00029 (logrank test), Q value = 0.0011

Table S42. Gene #12: 'amp_3q26.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 12(3Q26.2) MUTATED	163	39	0.1 - 225.5 (27.1)
AMP PEAK 12(3Q26.2) WILD-TYPE	371	42	0.0 - 185.8 (27.9)

Figure S42. Get High-res Image Gene #12: 'amp_3q26.2' versus Clinical Feature #1: 'Time to Death'

'amp_3q26.2' versus 'YEARS_TO_BIRTH'

P value = 1.31e-09 (Wilcoxon-test), Q value = 1.5e-07

Table S43. Gene #12: 'amp_3q26.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 12(3Q26.2) MUTATED	162	68.2 (9.4)
AMP PEAK 12(3Q26.2) WILD-TYPE	372	62.2 (11.4)

Figure S43. Get High-res Image Gene #12: 'amp_3q26.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_3q26.2' versus 'RADIATION_THERAPY'

P value = 0.0487 (Fisher's exact test), Q value = 0.1

Table S44. Gene #12: 'amp_3q26.2' versus Clinical Feature #3: 'RADIATION_THERAPY'

nPatients	NO	YES
ALL	284	218
AMP PEAK 12(3Q26.2) MUTATED	74	75
AMP PEAK 12(3Q26.2) WILD-TYPE	210	143

Figure S44. Get High-res Image Gene #12: 'amp_3q26.2' versus Clinical Feature #3: 'RADIATION_THERAPY'

'amp_3q26.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S45. Gene #12: 'amp_3q26.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 12(3Q26.2) MUTATED	67	8	88
AMP PEAK 12(3Q26.2) WILD-TYPE	334	14	25

Figure S45. Get High-res Image Gene #12: 'amp_3q26.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_3q26.2' versus 'RACE'

P value = 0.00019 (Fisher's exact test), Q value = 0.00076

Table S46. Gene #12: 'amp_3q26.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 12(3Q26.2) MUTATED	0	3	49	4	94
AMP PEAK 12(3Q26.2) WILD-TYPE	4	17	57	5	274

Figure S46. Get High-res Image Gene #12: 'amp_3q26.2' versus Clinical Feature #6: 'RACE'

'amp_4p16.3' versus 'Time to Death'

P value = 0.0611 (logrank test), Q value = 0.12

Table S47. Gene #13: 'amp_4p16.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 13(4P16.3) MUTATED	53	13	0.6 - 125.4 (23.9)
AMP PEAK 13(4P16.3) WILD-TYPE	481	68	0.0 - 225.5 (27.6)

Figure S47. Get High-res Image Gene #13: 'amp_4p16.3' versus Clinical Feature #1: 'Time to Death'

'amp_4p16.3' versus 'YEARS_TO_BIRTH'

P value = 1.66e-05 (Wilcoxon-test), Q value = 9e-05

Table S48. Gene #13: 'amp_4p16.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 13(4P16.3) MUTATED	53	69.7 (8.9)
AMP PEAK 13(4P16.3) WILD-TYPE	481	63.4 (11.3)

Figure S48. Get High-res Image Gene #13: 'amp_4p16.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_4p16.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S49. Gene #13: 'amp_4p16.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 13(4P16.3) MUTATED	15	2	36
AMP PEAK 13(4P16.3) WILD-TYPE	386	20	77

Figure S49. Get High-res Image Gene #13: 'amp_4p16.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_5p15.33' versus 'Time to Death'

P value = 0.000108 (logrank test), Q value = 0.00046

Table S50. Gene #14: 'amp_5p15.33' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 14(5P15.33) MUTATED	88	23	0.1 - 125.4 (22.3)
AMP PEAK 14(5P15.33) WILD-TYPE	446	58	0.0 - 225.5 (28.2)

Figure S50. Get High-res Image Gene #14: 'amp_5p15.33' versus Clinical Feature #1: 'Time to Death'

'amp_5p15.33' versus 'YEARS_TO_BIRTH'

P value = 0.000117 (Wilcoxon-test), Q value = 0.00049

Table S51. Gene #14: 'amp_5p15.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 14(5P15.33) MUTATED	89	67.6 (10.0)
AMP PEAK 14(5P15.33) WILD-TYPE	445	63.3 (11.3)

Figure S51. Get High-res Image Gene #14: 'amp_5p15.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_5p15.33' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S52. Gene #14: 'amp_5p15.33' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 14(5P15.33) MUTATED	30	3	56
AMP PEAK 14(5P15.33) WILD-TYPE	371	19	57

Figure S52. Get High-res Image Gene #14: 'amp_5p15.33' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_5p15.33' versus 'RACE'

P value = 0.0058 (Fisher's exact test), Q value = 0.016

Table S53. Gene #14: 'amp_5p15.33' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 14(5P15.33) MUTATED	1	2	30	2	50
AMP PEAK 14(5P15.33) WILD-TYPE	3	18	76	7	318

Figure S53. Get High-res Image Gene #14: 'amp_5p15.33' versus Clinical Feature #6: 'RACE'

'amp_5q35.3' versus 'Time to Death'

P value = 0.000627 (logrank test), Q value = 0.0022

Table S54. Gene #15: 'amp_5q35.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 15(5Q35.3) MUTATED	56	15	0.4 - 110.6 (20.6)
AMP PEAK 15(5Q35.3) WILD-TYPE	478	66	0.0 - 225.5 (28.6)

Figure S54. Get High-res Image Gene #15: 'amp_5q35.3' versus Clinical Feature #1: 'Time to Death'

'amp_5q35.3' versus 'YEARS_TO_BIRTH'

P value = 0.000166 (Wilcoxon-test), Q value = 0.00068

Table S55. Gene #15: 'amp_5q35.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 15(5Q35.3) MUTATED	57	69.2 (10.3)
AMP PEAK 15(5Q35.3) WILD-TYPE	477	63.4 (11.2)

Figure S55. Get High-res Image Gene #15: 'amp_5q35.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_5q35.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S56. Gene #15: 'amp_5q35.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 15(5Q35.3) MUTATED	22	3	32
AMP PEAK 15(5Q35.3) WILD-TYPE	379	19	81

Figure S56. Get High-res Image Gene #15: 'amp_5q35.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_5q35.3' versus 'RACE'

P value = 0.0197 (Fisher's exact test), Q value = 0.045

Table S57. Gene #15: 'amp_5q35.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 15(5Q35.3) MUTATED	0	1	21	0	31
AMP PEAK 15(5Q35.3) WILD-TYPE	4	19	85	9	337

Figure S57. Get High-res Image Gene #15: 'amp_5q35.3' versus Clinical Feature #6: 'RACE'

'amp_6p24.2' versus 'Time to Death'

P value = 0.0119 (logrank test), Q value = 0.029

Table S58. Gene #16: 'amp_6p24.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 16(6P24.2) MUTATED	116	28	0.1 - 125.4 (30.9)
AMP PEAK 16(6P24.2) WILD-TYPE	418	53	0.0 - 225.5 (26.4)

Figure S58. Get High-res Image Gene #16: 'amp_6p24.2' versus Clinical Feature #1: 'Time to Death'

'amp_6p24.2' versus 'YEARS_TO_BIRTH'

P value = 3.75e-06 (Wilcoxon-test), Q value = 5.5e-05

Table S59. Gene #16: 'amp_6p24.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 16(6P24.2) MUTATED	116	67.9 (9.9)
AMP PEAK 16(6P24.2) WILD-TYPE	418	62.9 (11.3)

Figure S59. Get High-res Image Gene #16: 'amp_6p24.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_6p24.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S60. Gene #16: 'amp_6p24.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 16(6P24.2) MUTATED	46	5	65
AMP PEAK 16(6P24.2) WILD-TYPE	355	17	48

Figure S60. Get High-res Image Gene #16: 'amp_6p24.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_6p22.3' versus 'Time to Death'

P value = 0.0718 (logrank test), Q value = 0.14

Table S61. Gene #17: 'amp_6p22.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 17(6P22.3) MUTATED	106	22	0.1 - 125.4 (27.2)
AMP PEAK 17(6P22.3) WILD-TYPE	428	59	0.0 - 225.5 (27.4)

Figure S61. Get High-res Image Gene #17: 'amp_6p22.3' versus Clinical Feature #1: 'Time to Death'

'amp_6p22.3' versus 'YEARS_TO_BIRTH'

P value = 0.000269 (Wilcoxon-test), Q value = 0.001

Table S62. Gene #17: 'amp_6p22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 17(6P22.3) MUTATED	106	67.3 (9.9)
AMP PEAK 17(6P22.3) WILD-TYPE	428	63.2 (11.4)

Figure S62. Get High-res Image Gene #17: 'amp_6p22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_6p22.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S63. Gene #17: 'amp_6p22.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 17(6P22.3) MUTATED	41	4	61
AMP PEAK 17(6P22.3) WILD-TYPE	360	18	52

Figure S63. Get High-res Image Gene #17: 'amp_6p22.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_6p22.3' versus 'RACE'

P value = 0.0174 (Fisher's exact test), Q value = 0.04

Table S64. Gene #17: 'amp_6p22.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 17(6P22.3) MUTATED	0	2	33	2	63
AMP PEAK 17(6P22.3) WILD-TYPE	4	18	73	7	305

Figure S64. Get High-res Image Gene #17: 'amp_6p22.3' versus Clinical Feature #6: 'RACE'

'amp_6q25.1' versus 'Time to Death'

P value = 0.0349 (logrank test), Q value = 0.076

Table S65. Gene #18: 'amp_6q25.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 18(6Q25.1) MUTATED	87	19	0.1 - 97.7 (27.3)
AMP PEAK 18(6Q25.1) WILD-TYPE	447	62	0.0 - 225.5 (27.4)

Figure S65. Get High-res Image Gene #18: 'amp_6q25.1' versus Clinical Feature #1: 'Time to Death'

'amp_6q25.1' versus 'YEARS_TO_BIRTH'

P value = 0.000802 (Wilcoxon-test), Q value = 0.0027

Table S66. Gene #18: 'amp_6q25.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 18(6Q25.1) MUTATED	87	67.2 (10.5)
AMP PEAK 18(6Q25.1) WILD-TYPE	447	63.4 (11.2)

Figure S66. Get High-res Image Gene #18: 'amp_6q25.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_6q25.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S67. Gene #18: 'amp_6q25.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 18(6Q25.1) MUTATED	46	3	38
AMP PEAK 18(6Q25.1) WILD-TYPE	355	19	75

Figure S67. Get High-res Image Gene #18: 'amp_6q25.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_6q25.1' versus 'RESIDUAL_TUMOR'

P value = 0.0648 (Fisher's exact test), Q value = 0.13

Table S68. Gene #18: 'amp_6q25.1' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
AMP PEAK 18(6Q25.1) MUTATED	53	1	4	10
AMP PEAK 18(6Q25.1) WILD-TYPE	317	21	13	27

Figure S68. Get High-res Image Gene #18: 'amp_6q25.1' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'amp_6q25.1' versus 'RACE'

P value = 0.00537 (Fisher's exact test), Q value = 0.015

Table S69. Gene #18: 'amp_6q25.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 18(6Q25.1) MUTATED	0	1	29	2	48
AMP PEAK 18(6Q25.1) WILD-TYPE	4	19	77	7	320

Figure S69. Get High-res Image Gene #18: 'amp_6q25.1' versus Clinical Feature #6: 'RACE'

'amp_7q31.2' versus 'Time to Death'

P value = 4.83e-05 (logrank test), Q value = 0.00024

Table S70. Gene #19: 'amp_7q31.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 19(7Q31.2) MUTATED	92	25	0.1 - 125.4 (20.8)
AMP PEAK 19(7Q31.2) WILD-TYPE	442	56	0.0 - 225.5 (28.3)

Figure S70. Get High-res Image Gene #19: 'amp_7q31.2' versus Clinical Feature #1: 'Time to Death'

'amp_7q31.2' versus 'YEARS_TO_BIRTH'

P value = 0.0798 (Wilcoxon-test), Q value = 0.15

Table S71. Gene #19: 'amp_7q31.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 19(7Q31.2) MUTATED	92	65.8 (12.0)
AMP PEAK 19(7Q31.2) WILD-TYPE	442	63.6 (11.0)

Figure S71. Get High-res Image Gene #19: 'amp_7q31.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_7q31.2' versus 'HISTOLOGICAL_TYPE'

P value = 5e-05 (Fisher's exact test), Q value = 0.00024

Table S72. Gene #19: 'amp_7q31.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 19(7Q31.2) MUTATED	53	5	35
AMP PEAK 19(7Q31.2) WILD-TYPE	348	17	78

Figure S72. Get High-res Image Gene #19: 'amp_7q31.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_8p11.22' versus 'Time to Death'

P value = 0.00875 (logrank test), Q value = 0.022

Table S73. Gene #20: 'amp_8p11.22' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 20(8P11.22) MUTATED	126	28	0.1 - 136.6 (26.3)
AMP PEAK 20(8P11.22) WILD-TYPE	408	53	0.0 - 225.5 (27.4)

Figure S73. Get High-res Image Gene #20: 'amp_8p11.22' versus Clinical Feature #1: 'Time to Death'

'amp_8p11.21' versus 'Time to Death'

P value = 8.79e-05 (logrank test), Q value = 0.00039

Table S74. Gene #21: 'amp_8p11.21' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 21(8P11.21) MUTATED	162	39	0.1 - 136.6 (24.2)
AMP PEAK 21(8P11.21) WILD-TYPE	372	42	0.0 - 225.5 (27.9)

Figure S74. Get High-res Image Gene #21: 'amp_8p11.21' versus Clinical Feature #1: 'Time to Death'

'amp_8p11.21' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S75. Gene #21: 'amp_8p11.21' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 21(8P11.21) MUTATED	95	7	60
AMP PEAK 21(8P11.21) WILD-TYPE	306	15	53

Figure S75. Get High-res Image Gene #21: 'amp_8p11.21' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_8p11.21' versus 'RESIDUAL_TUMOR'

P value = 0.00539 (Fisher's exact test), Q value = 0.015

Table S76. Gene #21: 'amp_8p11.21' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
AMP PEAK 21(8P11.21) MUTATED	106	4	11	15
AMP PEAK 21(8P11.21) WILD-TYPE	264	18	6	22

Figure S76. Get High-res Image Gene #21: 'amp_8p11.21' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'amp_8q24.21' versus 'Time to Death'

P value = 7.41e-05 (logrank test), Q value = 0.00034

Table S77. Gene #22: 'amp_8q24.21' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 22(8Q24.21) MUTATED	206	47	0.1 - 225.5 (24.0)
AMP PEAK 22(8Q24.21) WILD-TYPE	328	34	0.0 - 185.8 (28.8)

Figure S77. Get High-res Image Gene #22: 'amp_8q24.21' versus Clinical Feature #1: 'Time to Death'

'amp_8q24.21' versus 'YEARS_TO_BIRTH'

P value = 0.0211 (Wilcoxon-test), Q value = 0.048

Table S78. Gene #22: 'amp_8q24.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 22(8Q24.21) MUTATED	206	64.9 (11.8)
AMP PEAK 22(8Q24.21) WILD-TYPE	328	63.4 (10.8)

Figure S78. Get High-res Image Gene #22: 'amp_8q24.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_8q24.21' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S79. Gene #22: 'amp_8q24.21' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 22(8Q24.21) MUTATED	117	11	80
AMP PEAK 22(8Q24.21) WILD-TYPE	284	11	33

Figure S79. Get High-res Image Gene #22: 'amp_8q24.21' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_8q24.21' versus 'Time to Death'

P value = 2.42e-05 (logrank test), Q value = 0.00013

Table S80. Gene #23: 'amp_8q24.21' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 23(8Q24.21) MUTATED	212	49	0.1 - 225.5 (23.8)
AMP PEAK 23(8Q24.21) WILD-TYPE	322	32	0.0 - 185.8 (28.8)

Figure S80. Get High-res Image Gene #23: 'amp_8q24.21' versus Clinical Feature #1: 'Time to Death'

'amp_8q24.21' versus 'YEARS_TO_BIRTH'

P value = 0.00703 (Wilcoxon-test), Q value = 0.019

Table S81. Gene #23: 'amp_8q24.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 23(8Q24.21) MUTATED	212	65.2 (11.6)
AMP PEAK 23(8Q24.21) WILD-TYPE	322	63.2 (10.8)

Figure S81. Get High-res Image Gene #23: 'amp_8q24.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_8q24.21' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S82. Gene #23: 'amp_8q24.21' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 23(8Q24.21) MUTATED	120	10	84
AMP PEAK 23(8Q24.21) WILD-TYPE	281	12	29

Figure S82. Get High-res Image Gene #23: 'amp_8q24.21' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_8q24.21' versus 'RESIDUAL_TUMOR'

P value = 0.0125 (Fisher's exact test), Q value = 0.03

Table S83. Gene #23: 'amp_8q24.21' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
AMP PEAK 23(8Q24.21) MUTATED	144	6	13	15
AMP PEAK 23(8Q24.21) WILD-TYPE	226	16	4	22

Figure S83. Get High-res Image Gene #23: 'amp_8q24.21' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'amp_9p24.2' versus 'Time to Death'

P value = 0.00505 (logrank test), Q value = 0.014

Table S84. Gene #24: 'amp_9p24.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 24(9P24.2) MUTATED	63	18	0.1 - 125.4 (29.4)
AMP PEAK 24(9P24.2) WILD-TYPE	471	63	0.0 - 225.5 (27.2)

Figure S84. Get High-res Image Gene #24: 'amp_9p24.2' versus Clinical Feature #1: 'Time to Death'

'amp_9p24.2' versus 'YEARS_TO_BIRTH'

P value = 0.0017 (Wilcoxon-test), Q value = 0.0052

Table S85. Gene #24: 'amp_9p24.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 24(9P24.2) MUTATED	64	67.4 (9.2)
AMP PEAK 24(9P24.2) WILD-TYPE	470	63.5 (11.4)

Figure S85. Get High-res Image Gene #24: 'amp_9p24.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_9p24.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S86. Gene #24: 'amp_9p24.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 24(9P24.2) MUTATED	25	3	36
AMP PEAK 24(9P24.2) WILD-TYPE	376	19	77

Figure S86. Get High-res Image Gene #24: 'amp_9p24.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_9p24.2' versus 'ETHNICITY'

P value = 0.0274 (Fisher's exact test), Q value = 0.061

Table S87. Gene #24: 'amp_9p24.2' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	15	372
AMP PEAK 24(9P24.2) MUTATED	5	43
AMP PEAK 24(9P24.2) WILD-TYPE	10	329

Figure S87. Get High-res Image Gene #24: 'amp_9p24.2' versus Clinical Feature #7: 'ETHNICITY'

'amp_9q34.3' versus 'Time to Death'

P value = 0.046 (logrank test), Q value = 0.098

Table S88. Gene #25: 'amp_9q34.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 25(9Q34.3) MUTATED	39	9	0.1 - 71.2 (23.9)
AMP PEAK 25(9Q34.3) WILD-TYPE	495	72	0.0 - 225.5 (27.6)

Figure S88. Get High-res Image Gene #25: 'amp_9q34.3' versus Clinical Feature #1: 'Time to Death'

'amp_9q34.3' versus 'YEARS_TO_BIRTH'

P value = 0.00103 (Wilcoxon-test), Q value = 0.0033

Table S89. Gene #25: 'amp_9q34.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 25(9Q34.3) MUTATED	39	69.4 (8.0)
AMP PEAK 25(9Q34.3) WILD-TYPE	495	63.6 (11.3)

Figure S89. Get High-res Image Gene #25: 'amp_9q34.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_9q34.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S90. Gene #25: 'amp_9q34.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 25(9Q34.3) MUTATED	13	5	21
AMP PEAK 25(9Q34.3) WILD-TYPE	388	17	92

Figure S90. Get High-res Image Gene #25: 'amp_9q34.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_9q34.3' versus 'RACE'

P value = 0.00707 (Fisher's exact test), Q value = 0.019

Table S91. Gene #25: 'amp_9q34.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 25(9Q34.3) MUTATED	0	1	18	0	20
AMP PEAK 25(9Q34.3) WILD-TYPE	4	19	88	9	348

Figure S91. Get High-res Image Gene #25: 'amp_9q34.3' versus Clinical Feature #6: 'RACE'

'amp_10q22.2' versus 'Time to Death'

P value = 0.0713 (logrank test), Q value = 0.14

Table S92. Gene #26: 'amp_10q22.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 26(10Q22.2) MUTATED	142	29	0.6 - 185.8 (29.0)
AMP PEAK 26(10Q22.2) WILD-TYPE	392	52	0.0 - 225.5 (26.9)

Figure S92. Get High-res Image Gene #26: 'amp_10q22.2' versus Clinical Feature #1: 'Time to Death'

'amp_10q22.2' versus 'HISTOLOGICAL_TYPE'

P value = 0.003 (Fisher's exact test), Q value = 0.0087

Table S93. Gene #26: 'amp_10q22.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 26(10Q22.2) MUTATED	96	3	44
AMP PEAK 26(10Q22.2) WILD-TYPE	305	19	69

Figure S93. Get High-res Image Gene #26: 'amp_10q22.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_11p11.2' versus 'Time to Death'

P value = 0.000577 (logrank test), Q value = 0.002

Table S94. Gene #27: 'amp_11p11.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 27(11P11.2) MUTATED	51	16	1.3 - 110.6 (24.4)
AMP PEAK 27(11P11.2) WILD-TYPE	483	65	0.0 - 225.5 (27.9)

Figure S94. Get High-res Image Gene #27: 'amp_11p11.2' versus Clinical Feature #1: 'Time to Death'

'amp_11p11.2' versus 'YEARS_TO_BIRTH'

P value = 0.000293 (Wilcoxon-test), Q value = 0.0011

Table S95. Gene #27: 'amp_11p11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 27(11P11.2) MUTATED	51	69.5 (9.5)
AMP PEAK 27(11P11.2) WILD-TYPE	483	63.4 (11.2)

Figure S95. Get High-res Image Gene #27: 'amp_11p11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_11p11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S96. Gene #27: 'amp_11p11.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 27(11P11.2) MUTATED	17	4	30
AMP PEAK 27(11P11.2) WILD-TYPE	384	18	83

Figure S96. Get High-res Image Gene #27: 'amp_11p11.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_11q13.2' versus 'Time to Death'

P value = 0.00222 (logrank test), Q value = 0.0066

Table S97. Gene #28: 'amp_11q13.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 28(11Q13.2) MUTATED	73	19	0.1 - 92.9 (26.1)
AMP PEAK 28(11Q13.2) WILD-TYPE	461	62	0.0 - 225.5 (27.4)

Figure S97. Get High-res Image Gene #28: 'amp_11q13.2' versus Clinical Feature #1: 'Time to Death'

'amp_11q13.2' versus 'YEARS_TO_BIRTH'

P value = 0.000278 (Wilcoxon-test), Q value = 0.0011

Table S98. Gene #28: 'amp_11q13.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 28(11Q13.2) MUTATED	73	68.2 (10.0)
AMP PEAK 28(11Q13.2) WILD-TYPE	461	63.3 (11.2)

Figure S98. Get High-res Image Gene #28: 'amp_11q13.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_11q13.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S99. Gene #28: 'amp_11q13.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 28(11Q13.2) MUTATED	35	4	34
AMP PEAK 28(11Q13.2) WILD-TYPE	366	18	79

Figure S99. Get High-res Image Gene #28: 'amp_11q13.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_11q13.2' versus 'RESIDUAL_TUMOR'

P value = 0.0606 (Fisher's exact test), Q value = 0.12

Table S100. Gene #28: 'amp_11q13.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
AMP PEAK 28(11Q13.2) MUTATED	42	2	4	9
AMP PEAK 28(11Q13.2) WILD-TYPE	328	20	13	28

Figure S100. Get High-res Image Gene #28: 'amp_11q13.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'amp_11q14.1' versus 'Time to Death'

P value = 4.42e-06 (logrank test), Q value = 5.5e-05

Table S101. Gene #29: 'amp_11q14.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 29(11Q14.1) MUTATED	58	19	0.4 - 102.3 (22.5)
AMP PEAK 29(11Q14.1) WILD-TYPE	476	62	0.0 - 225.5 (27.9)

Figure S101. Get High-res Image Gene #29: 'amp_11q14.1' versus Clinical Feature #1: 'Time to Death'

'amp_11q14.1' versus 'YEARS_TO_BIRTH'

P value = 0.00721 (Wilcoxon-test), Q value = 0.019

Table S102. Gene #29: 'amp_11q14.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 29(11Q14.1) MUTATED	58	67.8 (10.8)
AMP PEAK 29(11Q14.1) WILD-TYPE	476	63.5 (11.2)

Figure S102. Get High-res Image Gene #29: 'amp_11q14.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_11q14.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S103. Gene #29: 'amp_11q14.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 29(11Q14.1) MUTATED	23	1	34
AMP PEAK 29(11Q14.1) WILD-TYPE	378	21	79

Figure S103. Get High-res Image Gene #29: 'amp_11q14.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_11q14.1' versus 'RESIDUAL_TUMOR'

P value = 0.115 (Fisher's exact test), Q value = 0.21

Table S104. Gene #29: 'amp_11q14.1' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
AMP PEAK 29(11Q14.1) MUTATED	33	1	3	7
AMP PEAK 29(11Q14.1) WILD-TYPE	337	21	14	30

Figure S104. Get High-res Image Gene #29: 'amp_11q14.1' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'amp_11q14.1' versus 'RACE'

P value = 0.122 (Fisher's exact test), Q value = 0.22

Table S105. Gene #29: 'amp_11q14.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 29(11Q14.1) MUTATED	1	0	16	1	35
AMP PEAK 29(11Q14.1) WILD-TYPE	3	20	90	8	333

Figure S105. Get High-res Image Gene #29: 'amp_11q14.1' versus Clinical Feature #6: 'RACE'

'amp_12p12.1' versus 'YEARS_TO_BIRTH'

P value = 0.095 (Wilcoxon-test), Q value = 0.18

Table S106. Gene #30: 'amp_12p12.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 30(12P12.1) MUTATED	92	65.6 (11.6)
AMP PEAK 30(12P12.1) WILD-TYPE	442	63.7 (11.1)

Figure S106. Get High-res Image Gene #30: 'amp_12p12.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_12p12.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S107. Gene #30: 'amp_12p12.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 30(12P12.1) MUTATED	45	4	44
AMP PEAK 30(12P12.1) WILD-TYPE	356	18	69

Figure S107. Get High-res Image Gene #30: 'amp_12p12.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_12p12.1' versus 'RACE'

P value = 0.144 (Fisher's exact test), Q value = 0.25

Table S108. Gene #30: 'amp_12p12.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 30(12P12.1) MUTATED	0	6	24	2	56
AMP PEAK 30(12P12.1) WILD-TYPE	4	14	82	7	312

Figure S108. Get High-res Image Gene #30: 'amp_12p12.1' versus Clinical Feature #6: 'RACE'

'amp_12p12.1' versus 'ETHNICITY'

P value = 0.0838 (Fisher's exact test), Q value = 0.16

Table S109. Gene #30: 'amp_12p12.1' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	15	372
AMP PEAK 30(12P12.1) MUTATED	0	68
AMP PEAK 30(12P12.1) WILD-TYPE	15	304

Figure S109. Get High-res Image Gene #30: 'amp_12p12.1' versus Clinical Feature #7: 'ETHNICITY'

'amp_12q13.11' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S110. Gene #31: 'amp_12q13.11' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 31(12Q13.11) MUTATED	40	4	42
AMP PEAK 31(12Q13.11) WILD-TYPE	361	18	71

Figure S110. Get High-res Image Gene #31: 'amp_12q13.11' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_12q13.11' versus 'RACE'

P value = 0.0296 (Fisher's exact test), Q value = 0.066

Table S111. Gene #31: 'amp_12q13.11' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 31(12Q13.11) MUTATED	1	6	23	3	50
AMP PEAK 31(12Q13.11) WILD-TYPE	3	14	83	6	318

Figure S111. Get High-res Image Gene #31: 'amp_12q13.11' versus Clinical Feature #6: 'RACE'

'amp_12q13.2' versus 'YEARS_TO_BIRTH'

P value = 0.0812 (Wilcoxon-test), Q value = 0.16

Table S112. Gene #32: 'amp_12q13.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 32(12Q13.2) MUTATED	99	65.5 (11.7)
AMP PEAK 32(12Q13.2) WILD-TYPE	435	63.6 (11.1)

Figure S112. Get High-res Image Gene #32: 'amp_12q13.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_12q13.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S113. Gene #32: 'amp_12q13.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 32(12Q13.2) MUTATED	50	4	45
AMP PEAK 32(12Q13.2) WILD-TYPE	351	18	68

Figure S113. Get High-res Image Gene #32: 'amp_12q13.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_13q34' versus 'Time to Death'

P value = 0.0863 (logrank test), Q value = 0.16

Table S114. Gene #33: 'amp_13q34' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 33(13Q34) MUTATED	58	13	0.6 - 125.4 (23.9)
AMP PEAK 33(13Q34) WILD-TYPE	476	68	0.0 - 225.5 (27.9)

Figure S114. Get High-res Image Gene #33: 'amp_13q34' versus Clinical Feature #1: 'Time to Death'

'amp_13q34' versus 'YEARS_TO_BIRTH'

P value = 0.000103 (Wilcoxon-test), Q value = 0.00044

Table S115. Gene #33: 'amp_13q34' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 33(13Q34) MUTATED	58	69.0 (7.5)
AMP PEAK 33(13Q34) WILD-TYPE	476	63.4 (11.4)

Figure S115. Get High-res Image Gene #33: 'amp_13q34' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_13q34' versus 'RADIATION_THERAPY'

P value = 0.00395 (Fisher's exact test), Q value = 0.011

Table S116. Gene #33: 'amp_13q34' versus Clinical Feature #3: 'RADIATION_THERAPY'

nPatients	NO	YES
ALL	284	218
AMP PEAK 33(13Q34) MUTATED	21	34
AMP PEAK 33(13Q34) WILD-TYPE	263	184

Figure S116. Get High-res Image Gene #33: 'amp_13q34' versus Clinical Feature #3: 'RADIATION_THERAPY'

'amp_13q34' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S117. Gene #33: 'amp_13q34' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 33(13Q34) MUTATED	14	4	40
AMP PEAK 33(13Q34) WILD-TYPE	387	18	73

Figure S117. Get High-res Image Gene #33: 'amp_13q34' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_13q34' versus 'RESIDUAL_TUMOR'

P value = 0.0133 (Fisher's exact test), Q value = 0.032

Table S118. Gene #33: 'amp_13q34' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
AMP PEAK 33(13Q34) MUTATED	35	6	4	6
AMP PEAK 33(13Q34) WILD-TYPE	335	16	13	31

Figure S118. Get High-res Image Gene #33: 'amp_13q34' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'amp_13q34' versus 'RACE'

P value = 0.104 (Fisher's exact test), Q value = 0.19

Table S119. Gene #33: 'amp_13q34' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 33(13Q34) MUTATED	0	2	18	2	33
AMP PEAK 33(13Q34) WILD-TYPE	4	18	88	7	335

Figure S119. Get High-res Image Gene #33: 'amp_13q34' versus Clinical Feature #6: 'RACE'

'amp_14q24.3' versus 'Time to Death'

P value = 0.00207 (logrank test), Q value = 0.0062

Table S120. Gene #34: 'amp_14q24.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 34(14Q24.3) MUTATED	64	20	0.4 - 125.4 (28.8)
AMP PEAK 34(14Q24.3) WILD-TYPE	470	61	0.0 - 225.5 (27.3)

Figure S120. Get High-res Image Gene #34: 'amp_14q24.3' versus Clinical Feature #1: 'Time to Death'

'amp_14q24.3' versus 'YEARS_TO_BIRTH'

P value = 0.0021 (Wilcoxon-test), Q value = 0.0063

Table S121. Gene #34: 'amp_14q24.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 34(14Q24.3) MUTATED	64	67.8 (9.2)
AMP PEAK 34(14Q24.3) WILD-TYPE	470	63.5 (11.4)

Figure S121. Get High-res Image Gene #34: 'amp_14q24.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_14q24.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S122. Gene #34: 'amp_14q24.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 34(14Q24.3) MUTATED	22	4	38
AMP PEAK 34(14Q24.3) WILD-TYPE	379	18	75

Figure S122. Get High-res Image Gene #34: 'amp_14q24.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_14q32.33' versus 'Time to Death'

P value = 0.0037 (logrank test), Q value = 0.011

Table S123. Gene #35: 'amp_14q32.33' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 35(14Q32.33) MUTATED	78	21	0.3 - 118.2 (28.0)
AMP PEAK 35(14Q32.33) WILD-TYPE	456	60	0.0 - 225.5 (27.3)

Figure S123. Get High-res Image Gene #35: 'amp_14q32.33' versus Clinical Feature #1: 'Time to Death'

'amp_14q32.33' versus 'YEARS_TO_BIRTH'

P value = 0.00132 (Wilcoxon-test), Q value = 0.0041

Table S124. Gene #35: 'amp_14q32.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 35(14Q32.33) MUTATED	79	67.5 (9.4)
AMP PEAK 35(14Q32.33) WILD-TYPE	455	63.4 (11.4)

Figure S124. Get High-res Image Gene #35: 'amp_14q32.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_14q32.33' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S125. Gene #35: 'amp_14q32.33' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 35(14Q32.33) MUTATED	33	5	41
AMP PEAK 35(14Q32.33) WILD-TYPE	368	17	72

Figure S125. Get High-res Image Gene #35: 'amp_14q32.33' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_14q32.33' versus 'RACE'

P value = 0.0183 (Fisher's exact test), Q value = 0.042

Table S126. Gene #35: 'amp_14q32.33' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 35(14Q32.33) MUTATED	0	0	24	2	46
AMP PEAK 35(14Q32.33) WILD-TYPE	4	20	82	7	322

Figure S126. Get High-res Image Gene #35: 'amp_14q32.33' versus Clinical Feature #6: 'RACE'

'amp_15q26.3' versus 'Time to Death'

P value = 0.00787 (logrank test), Q value = 0.02

Table S127. Gene #36: 'amp_15q26.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 36(15Q26.3) MUTATED	37	12	1.3 - 110.1 (30.1)
AMP PEAK 36(15Q26.3) WILD-TYPE	497	69	0.0 - 225.5 (27.2)

Figure S127. Get High-res Image Gene #36: 'amp_15q26.3' versus Clinical Feature #1: 'Time to Death'

'amp_15q26.3' versus 'YEARS_TO_BIRTH'

P value = 0.00309 (Wilcoxon-test), Q value = 0.0089

Table S128. Gene #36: 'amp_15q26.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 36(15Q26.3) MUTATED	37	68.9 (11.2)
AMP PEAK 36(15Q26.3) WILD-TYPE	497	63.6 (11.1)

Figure S128. Get High-res Image Gene #36: 'amp_15q26.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_15q26.3' versus 'RADIATION_THERAPY'

P value = 0.0774 (Fisher's exact test), Q value = 0.15

Table S129. Gene #36: 'amp_15q26.3' versus Clinical Feature #3: 'RADIATION_THERAPY'

nPatients	NO	YES
ALL	284	218
AMP PEAK 36(15Q26.3) MUTATED	25	10
AMP PEAK 36(15Q26.3) WILD-TYPE	259	208

Figure S129. Get High-res Image Gene #36: 'amp_15q26.3' versus Clinical Feature #3: 'RADIATION_THERAPY'

'amp_15q26.3' versus 'HISTOLOGICAL_TYPE'

P value = 9e-05 (Fisher's exact test), Q value = 4e-04

Table S130. Gene #36: 'amp_15q26.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 36(15Q26.3) MUTATED	17	1	19
AMP PEAK 36(15Q26.3) WILD-TYPE	384	21	94

Figure S130. Get High-res Image Gene #36: 'amp_15q26.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_15q26.3' versus 'RESIDUAL_TUMOR'

P value = 0.0116 (Fisher's exact test), Q value = 0.028

Table S131. Gene #36: 'amp_15q26.3' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
AMP PEAK 36(15Q26.3) MUTATED	20	3	4	4
AMP PEAK 36(15Q26.3) WILD-TYPE	350	19	13	33

Figure S131. Get High-res Image Gene #36: 'amp_15q26.3' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'amp_16p11.2' versus 'Time to Death'

P value = 0.0474 (logrank test), Q value = 0.1

Table S132. Gene #37: 'amp_16p11.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 37(16P11.2) MUTATED	66	15	0.1 - 118.2 (24.3)
AMP PEAK 37(16P11.2) WILD-TYPE	468	66	0.0 - 225.5 (27.8)

Figure S132. Get High-res Image Gene #37: 'amp_16p11.2' versus Clinical Feature #1: 'Time to Death'

'amp_16p11.2' versus 'YEARS_TO_BIRTH'

P value = 0.000193 (Wilcoxon-test), Q value = 0.00077

Table S133. Gene #37: 'amp_16p11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 37(16P11.2) MUTATED	66	68.5 (9.0)
AMP PEAK 37(16P11.2) WILD-TYPE	468	63.4 (11.3)

Figure S133. Get High-res Image Gene #37: 'amp_16p11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_16p11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S134. Gene #37: 'amp_16p11.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 37(16P11.2) MUTATED	23	2	41
AMP PEAK 37(16P11.2) WILD-TYPE	378	20	72

Figure S134. Get High-res Image Gene #37: 'amp_16p11.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_16p11.2' versus 'RESIDUAL_TUMOR'

P value = 0.0423 (Fisher's exact test), Q value = 0.091

Table S135. Gene #37: 'amp_16p11.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
AMP PEAK 37(16P11.2) MUTATED	41	3	3	10
AMP PEAK 37(16P11.2) WILD-TYPE	329	19	14	27

Figure S135. Get High-res Image Gene #37: 'amp_16p11.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'amp_17q11.2' versus 'Time to Death'

P value = 3.81e-05 (logrank test), Q value = 2e-04

Table S136. Gene #38: 'amp_17q11.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 38(17Q11.2) MUTATED	71	21	0.1 - 118.2 (22.4)
AMP PEAK 38(17Q11.2) WILD-TYPE	463	60	0.0 - 225.5 (27.9)

Figure S136. Get High-res Image Gene #38: 'amp_17q11.2' versus Clinical Feature #1: 'Time to Death'

'amp_17q11.2' versus 'YEARS_TO_BIRTH'

P value = 0.00519 (Wilcoxon-test), Q value = 0.014

Table S137. Gene #38: 'amp_17q11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 38(17Q11.2) MUTATED	70	67.5 (8.6)
AMP PEAK 38(17Q11.2) WILD-TYPE	464	63.5 (11.5)

Figure S137. Get High-res Image Gene #38: 'amp_17q11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_17q11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S138. Gene #38: 'amp_17q11.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 38(17Q11.2) MUTATED	19	6	46
AMP PEAK 38(17Q11.2) WILD-TYPE	382	16	67

Figure S138. Get High-res Image Gene #38: 'amp_17q11.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_17q11.2' versus 'RESIDUAL_TUMOR'

P value = 0.00106 (Fisher's exact test), Q value = 0.0034

Table S139. Gene #38: 'amp_17q11.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
AMP PEAK 38(17Q11.2) MUTATED	39	7	6	7
AMP PEAK 38(17Q11.2) WILD-TYPE	331	15	11	30

Figure S139. Get High-res Image Gene #38: 'amp_17q11.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'amp_17q11.2' versus 'RACE'

P value = 0.00395 (Fisher's exact test), Q value = 0.011

Table S140. Gene #38: 'amp_17q11.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 38(17Q11.2) MUTATED	1	1	25	2	38
AMP PEAK 38(17Q11.2) WILD-TYPE	3	19	81	7	330

Figure S140. Get High-res Image Gene #38: 'amp_17q11.2' versus Clinical Feature #6: 'RACE'

'amp_17q12' versus 'Time to Death'

P value = 7.16e-05 (logrank test), Q value = 0.00033

Table S141. Gene #39: 'amp_17q12' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 39(17Q12) MUTATED	75	22	0.1 - 110.6 (24.1)
AMP PEAK 39(17Q12) WILD-TYPE	459	59	0.0 - 225.5 (27.9)

Figure S141. Get High-res Image Gene #39: 'amp_17q12' versus Clinical Feature #1: 'Time to Death'

'amp_17q12' versus 'YEARS_TO_BIRTH'

P value = 0.0018 (Wilcoxon-test), Q value = 0.0055

Table S142. Gene #39: 'amp_17q12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 39(17Q12) MUTATED	74	68.0 (9.1)
AMP PEAK 39(17Q12) WILD-TYPE	460	63.3 (11.4)

Figure S142. Get High-res Image Gene #39: 'amp_17q12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_17q12' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S143. Gene #39: 'amp_17q12' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 39(17Q12) MUTATED	20	4	51
AMP PEAK 39(17Q12) WILD-TYPE	381	18	62

Figure S143. Get High-res Image Gene #39: 'amp_17q12' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_17q12' versus 'RACE'

P value = 0.00462 (Fisher's exact test), Q value = 0.013

Table S144. Gene #39: 'amp_17q12' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 39(17Q12) MUTATED	1	0	26	0	47
AMP PEAK 39(17Q12) WILD-TYPE	3	20	80	9	321

Figure S144. Get High-res Image Gene #39: 'amp_17q12' versus Clinical Feature #6: 'RACE'

'amp_17q25.1' versus 'Time to Death'

P value = 5.98e-06 (logrank test), Q value = 5.5e-05

Table S145. Gene #40: 'amp_17q25.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 40(17Q25.1) MUTATED	104	30	0.1 - 125.4 (22.5)
AMP PEAK 40(17Q25.1) WILD-TYPE	430	51	0.0 - 225.5 (28.5)

Figure S145. Get High-res Image Gene #40: 'amp_17q25.1' versus Clinical Feature #1: 'Time to Death'

'amp_17q25.1' versus 'YEARS_TO_BIRTH'

P value = 0.00146 (Wilcoxon-test), Q value = 0.0045

Table S146. Gene #40: 'amp_17q25.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 40(17Q25.1) MUTATED	103	67.2 (9.1)
AMP PEAK 40(17Q25.1) WILD-TYPE	431	63.2 (11.5)

Figure S146. Get High-res Image Gene #40: 'amp_17q25.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_17q25.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S147. Gene #40: 'amp_17q25.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 40(17Q25.1) MUTATED	38	9	57
AMP PEAK 40(17Q25.1) WILD-TYPE	363	13	56

Figure S147. Get High-res Image Gene #40: 'amp_17q25.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_17q25.1' versus 'RESIDUAL_TUMOR'

P value = 0.125 (Fisher's exact test), Q value = 0.22

Table S148. Gene #40: 'amp_17q25.1' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
AMP PEAK 40(17Q25.1) MUTATED	66	4	5	12
AMP PEAK 40(17Q25.1) WILD-TYPE	304	18	12	25

Figure S148. Get High-res Image Gene #40: 'amp_17q25.1' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'amp_17q25.1' versus 'RACE'

P value = 1e-04 (Fisher's exact test), Q value = 0.00043

Table S149. Gene #40: 'amp_17q25.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 40(17Q25.1) MUTATED	0	0	36	2	60
AMP PEAK 40(17Q25.1) WILD-TYPE	4	20	70	7	308

Figure S149. Get High-res Image Gene #40: 'amp_17q25.1' versus Clinical Feature #6: 'RACE'

'amp_18p11.31' versus 'Time to Death'

P value = 0.0119 (logrank test), Q value = 0.029

Table S150. Gene #41: 'amp_18p11.31' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 41(18P11.31) MUTATED	96	23	0.4 - 125.4 (29.0)
AMP PEAK 41(18P11.31) WILD-TYPE	438	58	0.0 - 225.5 (27.2)

Figure S150. Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #1: 'Time to Death'

'amp_18p11.31' versus 'YEARS_TO_BIRTH'

P value = 4.7e-05 (Wilcoxon-test), Q value = 0.00024

Table S151. Gene #41: 'amp_18p11.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 41(18P11.31) MUTATED	95	68.0 (9.2)
AMP PEAK 41(18P11.31) WILD-TYPE	439	63.1 (11.4)

Figure S151. Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_18p11.31' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S152. Gene #41: 'amp_18p11.31' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 41(18P11.31) MUTATED	30	6	60
AMP PEAK 41(18P11.31) WILD-TYPE	371	16	53

Figure S152. Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_18p11.31' versus 'RESIDUAL_TUMOR'

P value = 0.0253 (Fisher's exact test), Q value = 0.057

Table S153. Gene #41: 'amp_18p11.31' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
AMP PEAK 41(18P11.31) MUTATED	62	3	8	8
AMP PEAK 41(18P11.31) WILD-TYPE	308	19	9	29

Figure S153. Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'amp_18p11.31' versus 'RACE'

P value = 0.00428 (Fisher's exact test), Q value = 0.012

Table S154. Gene #41: 'amp_18p11.31' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 41(18P11.31) MUTATED	0	3	33	1	54
AMP PEAK 41(18P11.31) WILD-TYPE	4	17	73	8	314

Figure S154. Get High-res Image Gene #41: 'amp_18p11.31' versus Clinical Feature #6: 'RACE'

'amp_18q11.2' versus 'Time to Death'

P value = 0.0215 (logrank test), Q value = 0.049

Table S155. Gene #42: 'amp_18q11.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 42(18Q11.2) MUTATED	69	18	1.4 - 125.4 (29.4)
AMP PEAK 42(18Q11.2) WILD-TYPE	465	63	0.0 - 225.5 (27.2)

Figure S155. Get High-res Image Gene #42: 'amp_18q11.2' versus Clinical Feature #1: 'Time to Death'

'amp_18q11.2' versus 'YEARS_TO_BIRTH'

P value = 0.000936 (Wilcoxon-test), Q value = 0.0031

Table S156. Gene #42: 'amp_18q11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 42(18Q11.2) MUTATED	68	68.2 (10.2)
AMP PEAK 42(18Q11.2) WILD-TYPE	466	63.4 (11.2)

Figure S156. Get High-res Image Gene #42: 'amp_18q11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_18q11.2' versus 'RADIATION_THERAPY'

P value = 0.14 (Fisher's exact test), Q value = 0.24

Table S157. Gene #42: 'amp_18q11.2' versus Clinical Feature #3: 'RADIATION_THERAPY'

nPatients	NO	YES
ALL	284	218
AMP PEAK 42(18Q11.2) MUTATED	31	34
AMP PEAK 42(18Q11.2) WILD-TYPE	253	184

Figure S157. Get High-res Image Gene #42: 'amp_18q11.2' versus Clinical Feature #3: 'RADIATION_THERAPY'

'amp_18q11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S158. Gene #42: 'amp_18q11.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 42(18Q11.2) MUTATED	21	4	44
AMP PEAK 42(18Q11.2) WILD-TYPE	380	18	69

Figure S158. Get High-res Image Gene #42: 'amp_18q11.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_18q11.2' versus 'RESIDUAL_TUMOR'

P value = 0.0447 (Fisher's exact test), Q value = 0.095

Table S159. Gene #42: 'amp_18q11.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
AMP PEAK 42(18Q11.2) MUTATED	43	1	4	9
AMP PEAK 42(18Q11.2) WILD-TYPE	327	21	13	28

Figure S159. Get High-res Image Gene #42: 'amp_18q11.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'amp_18q11.2' versus 'RACE'

P value = 0.0118 (Fisher's exact test), Q value = 0.029

Table S160. Gene #42: 'amp_18q11.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 42(18Q11.2) MUTATED	0	1	25	1	39
AMP PEAK 42(18Q11.2) WILD-TYPE	4	19	81	8	329

Figure S160. Get High-res Image Gene #42: 'amp_18q11.2' versus Clinical Feature #6: 'RACE'

'amp_19p13.2' versus 'Time to Death'

P value = 0.0141 (logrank test), Q value = 0.034

Table S161. Gene #43: 'amp_19p13.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 43(19P13.2) MUTATED	97	22	0.1 - 125.4 (24.4)
AMP PEAK 43(19P13.2) WILD-TYPE	437	59	0.0 - 225.5 (28.0)

Figure S161. Get High-res Image Gene #43: 'amp_19p13.2' versus Clinical Feature #1: 'Time to Death'

'amp_19p13.2' versus 'YEARS_TO_BIRTH'

P value = 5.58e-10 (Wilcoxon-test), Q value = 7.8e-08

Table S162. Gene #43: 'amp_19p13.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 43(19P13.2) MUTATED	97	70.1 (8.6)
AMP PEAK 43(19P13.2) WILD-TYPE	437	62.6 (11.3)

Figure S162. Get High-res Image Gene #43: 'amp_19p13.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_19p13.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S163. Gene #43: 'amp_19p13.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 43(19P13.2) MUTATED	26	7	65
AMP PEAK 43(19P13.2) WILD-TYPE	375	15	48

Figure S163. Get High-res Image Gene #43: 'amp_19p13.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_19p13.2' versus 'RACE'

P value = 0.00305 (Fisher's exact test), Q value = 0.0089

Table S164. Gene #43: 'amp_19p13.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 43(19P13.2) MUTATED	0	0	31	2	59
AMP PEAK 43(19P13.2) WILD-TYPE	4	20	75	7	309

Figure S164. Get High-res Image Gene #43: 'amp_19p13.2' versus Clinical Feature #6: 'RACE'

'amp_19q12' versus 'Time to Death'

P value = 6.05e-06 (logrank test), Q value = 5.5e-05

Table S165. Gene #44: 'amp_19q12' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 44(19Q12) MUTATED	119	32	0.1 - 125.4 (22.3)
AMP PEAK 44(19Q12) WILD-TYPE	415	49	0.0 - 225.5 (29.1)

Figure S165. Get High-res Image Gene #44: 'amp_19q12' versus Clinical Feature #1: 'Time to Death'

'amp_19q12' versus 'YEARS_TO_BIRTH'

P value = 6.64e-09 (Wilcoxon-test), Q value = 4.5e-07

Table S166. Gene #44: 'amp_19q12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 44(19Q12) MUTATED	119	68.9 (8.6)
AMP PEAK 44(19Q12) WILD-TYPE	415	62.6 (11.5)

Figure S166. Get High-res Image Gene #44: 'amp_19q12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_19q12' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S167. Gene #44: 'amp_19q12' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 44(19Q12) MUTATED	31	11	78
AMP PEAK 44(19Q12) WILD-TYPE	370	11	35

Figure S167. Get High-res Image Gene #44: 'amp_19q12' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_19q12' versus 'RESIDUAL_TUMOR'

P value = 0.112 (Fisher's exact test), Q value = 0.2

Table S168. Gene #44: 'amp_19q12' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
AMP PEAK 44(19Q12) MUTATED	76	5	6	13
AMP PEAK 44(19Q12) WILD-TYPE	294	17	11	24

Figure S168. Get High-res Image Gene #44: 'amp_19q12' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'amp_19q12' versus 'RACE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S169. Gene #44: 'amp_19q12' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 44(19Q12) MUTATED	1	2	44	3	63
AMP PEAK 44(19Q12) WILD-TYPE	3	18	62	6	305

Figure S169. Get High-res Image Gene #44: 'amp_19q12' versus Clinical Feature #6: 'RACE'

'amp_20p13' versus 'Time to Death'

P value = 0.071 (logrank test), Q value = 0.14

Table S170. Gene #45: 'amp_20p13' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 45(20P13) MUTATED	117	23	0.1 - 136.6 (25.9)
AMP PEAK 45(20P13) WILD-TYPE	417	58	0.0 - 225.5 (28.0)

Figure S170. Get High-res Image Gene #45: 'amp_20p13' versus Clinical Feature #1: 'Time to Death'

'amp_20p13' versus 'YEARS_TO_BIRTH'

P value = 2.74e-06 (Wilcoxon-test), Q value = 5.5e-05

Table S171. Gene #45: 'amp_20p13' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 45(20P13) MUTATED	117	67.8 (10.8)
AMP PEAK 45(20P13) WILD-TYPE	417	62.9 (11.1)

Figure S171. Get High-res Image Gene #45: 'amp_20p13' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_20p13' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S172. Gene #45: 'amp_20p13' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 45(20P13) MUTATED	53	5	59
AMP PEAK 45(20P13) WILD-TYPE	348	17	54

Figure S172. Get High-res Image Gene #45: 'amp_20p13' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_20p13' versus 'RACE'

P value = 0.077 (Fisher's exact test), Q value = 0.15

Table S173. Gene #45: 'amp_20p13' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 45(20P13) MUTATED	0	4	33	2	69
AMP PEAK 45(20P13) WILD-TYPE	4	16	73	7	299

Figure S173. Get High-res Image Gene #45: 'amp_20p13' versus Clinical Feature #6: 'RACE'

'amp_20q11.21' versus 'Time to Death'

P value = 2.69e-06 (logrank test), Q value = 5.5e-05

Table S174. Gene #46: 'amp_20q11.21' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 46(20Q11.21) MUTATED	150	39	0.0 - 149.6 (25.7)
AMP PEAK 46(20Q11.21) WILD-TYPE	384	42	0.1 - 225.5 (28.5)

Figure S174. Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #1: 'Time to Death'

'amp_20q11.21' versus 'YEARS_TO_BIRTH'

P value = 9.13e-09 (Wilcoxon-test), Q value = 5.3e-07

Table S175. Gene #46: 'amp_20q11.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 46(20Q11.21) MUTATED	151	68.2 (9.8)
AMP PEAK 46(20Q11.21) WILD-TYPE	383	62.3 (11.3)

Figure S175. Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_20q11.21' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S176. Gene #46: 'amp_20q11.21' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 46(20Q11.21) MUTATED	64	6	81
AMP PEAK 46(20Q11.21) WILD-TYPE	337	16	32

Figure S176. Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_20q11.21' versus 'RESIDUAL_TUMOR'

P value = 0.0737 (Fisher's exact test), Q value = 0.15

Table S177. Gene #46: 'amp_20q11.21' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
AMP PEAK 46(20Q11.21) MUTATED	93	5	9	12
AMP PEAK 46(20Q11.21) WILD-TYPE	277	17	8	25

Figure S177. Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'amp_20q11.21' versus 'RACE'

P value = 0.0158 (Fisher's exact test), Q value = 0.037

Table S178. Gene #46: 'amp_20q11.21' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 46(20Q11.21) MUTATED	1	5	43	3	88
AMP PEAK 46(20Q11.21) WILD-TYPE	3	15	63	6	280

Figure S178. Get High-res Image Gene #46: 'amp_20q11.21' versus Clinical Feature #6: 'RACE'

'amp_20q13.12' versus 'Time to Death'

P value = 0.000623 (logrank test), Q value = 0.0021

Table S179. Gene #47: 'amp_20q13.12' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 47(20Q13.12) MUTATED	150	36	0.0 - 225.5 (26.0)
AMP PEAK 47(20Q13.12) WILD-TYPE	384	45	0.1 - 185.8 (27.9)

Figure S179. Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #1: 'Time to Death'

'amp_20q13.12' versus 'YEARS_TO_BIRTH'

P value = 6.59e-09 (Wilcoxon-test), Q value = 4.5e-07

Table S180. Gene #47: 'amp_20q13.12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 47(20Q13.12) MUTATED	150	68.3 (10.0)
AMP PEAK 47(20Q13.12) WILD-TYPE	384	62.3 (11.2)

Figure S180. Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_20q13.12' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S181. Gene #47: 'amp_20q13.12' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 47(20Q13.12) MUTATED	66	7	78
AMP PEAK 47(20Q13.12) WILD-TYPE	335	15	35

Figure S181. Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_20q13.12' versus 'RESIDUAL_TUMOR'

P value = 0.0265 (Fisher's exact test), Q value = 0.059

Table S182. Gene #47: 'amp_20q13.12' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
AMP PEAK 47(20Q13.12) MUTATED	91	7	9	14
AMP PEAK 47(20Q13.12) WILD-TYPE	279	15	8	23

Figure S182. Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'amp_20q13.12' versus 'RACE'

P value = 0.0156 (Fisher's exact test), Q value = 0.037

Table S183. Gene #47: 'amp_20q13.12' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 47(20Q13.12) MUTATED	1	5	43	3	88
AMP PEAK 47(20Q13.12) WILD-TYPE	3	15	63	6	280

Figure S183. Get High-res Image Gene #47: 'amp_20q13.12' versus Clinical Feature #6: 'RACE'

'amp_20q13.33' versus 'Time to Death'

P value = 0.00157 (logrank test), Q value = 0.0048

Table S184. Gene #48: 'amp_20q13.33' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 48(20Q13.33) MUTATED	151	35	0.0 - 225.5 (25.9)
AMP PEAK 48(20Q13.33) WILD-TYPE	383	46	0.1 - 185.8 (28.0)

Figure S184. Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #1: 'Time to Death'

'amp_20q13.33' versus 'YEARS_TO_BIRTH'

P value = 1.75e-08 (Wilcoxon-test), Q value = 8.2e-07

Table S185. Gene #48: 'amp_20q13.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 48(20Q13.33) MUTATED	151	68.1 (10.3)
AMP PEAK 48(20Q13.33) WILD-TYPE	383	62.4 (11.1)

Figure S185. Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_20q13.33' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S186. Gene #48: 'amp_20q13.33' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 48(20Q13.33) MUTATED	69	6	77
AMP PEAK 48(20Q13.33) WILD-TYPE	332	16	36

Figure S186. Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_20q13.33' versus 'RESIDUAL_TUMOR'

P value = 0.00494 (Fisher's exact test), Q value = 0.014

Table S187. Gene #48: 'amp_20q13.33' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
AMP PEAK 48(20Q13.33) MUTATED	91	7	10	15
AMP PEAK 48(20Q13.33) WILD-TYPE	279	15	7	22

Figure S187. Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'amp_20q13.33' versus 'RACE'

P value = 0.0776 (Fisher's exact test), Q value = 0.15

Table S188. Gene #48: 'amp_20q13.33' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 48(20Q13.33) MUTATED	1	6	41	3	92
AMP PEAK 48(20Q13.33) WILD-TYPE	3	14	65	6	276

Figure S188. Get High-res Image Gene #48: 'amp_20q13.33' versus Clinical Feature #6: 'RACE'

'amp_22q12.2' versus 'Time to Death'

P value = 7.64e-05 (logrank test), Q value = 0.00035

Table S189. Gene #49: 'amp_22q12.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 49(22Q12.2) MUTATED	61	20	0.4 - 225.5 (27.4)
AMP PEAK 49(22Q12.2) WILD-TYPE	473	61	0.0 - 185.8 (27.4)

Figure S189. Get High-res Image Gene #49: 'amp_22q12.2' versus Clinical Feature #1: 'Time to Death'

'amp_22q12.2' versus 'YEARS_TO_BIRTH'

P value = 0.000511 (Wilcoxon-test), Q value = 0.0018

Table S190. Gene #49: 'amp_22q12.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 49(22Q12.2) MUTATED	61	68.3 (10.1)
AMP PEAK 49(22Q12.2) WILD-TYPE	473	63.4 (11.2)

Figure S190. Get High-res Image Gene #49: 'amp_22q12.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_22q12.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S191. Gene #49: 'amp_22q12.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 49(22Q12.2) MUTATED	11	2	49
AMP PEAK 49(22Q12.2) WILD-TYPE	390	20	64

Figure S191. Get High-res Image Gene #49: 'amp_22q12.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_22q12.2' versus 'RESIDUAL_TUMOR'

P value = 0.00214 (Fisher's exact test), Q value = 0.0063

Table S192. Gene #49: 'amp_22q12.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
AMP PEAK 49(22Q12.2) MUTATED	35	3	7	6
AMP PEAK 49(22Q12.2) WILD-TYPE	335	19	10	31

Figure S192. Get High-res Image Gene #49: 'amp_22q12.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'amp_22q12.2' versus 'RACE'

P value = 0.0386 (Fisher's exact test), Q value = 0.083

Table S193. Gene #49: 'amp_22q12.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
AMP PEAK 49(22Q12.2) MUTATED	0	1	21	0	34
AMP PEAK 49(22Q12.2) WILD-TYPE	4	19	85	9	334

Figure S193. Get High-res Image Gene #49: 'amp_22q12.2' versus Clinical Feature #6: 'RACE'

'amp_xp11.23' versus 'YEARS_TO_BIRTH'

P value = 0.0169 (Wilcoxon-test), Q value = 0.039

Table S194. Gene #50: 'amp_xp11.23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 50(XP11.23) MUTATED	90	66.4 (11.3)
AMP PEAK 50(XP11.23) WILD-TYPE	444	63.5 (11.1)

Figure S194. Get High-res Image Gene #50: 'amp_xp11.23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_xp11.23' versus 'HISTOLOGICAL_TYPE'

P value = 0.00047 (Fisher's exact test), Q value = 0.0017

Table S195. Gene #50: 'amp_xp11.23' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 50(XP11.23) MUTATED	53	4	33
AMP PEAK 50(XP11.23) WILD-TYPE	348	18	80

Figure S195. Get High-res Image Gene #50: 'amp_xp11.23' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'amp_xq28' versus 'Time to Death'

P value = 8e-04 (logrank test), Q value = 0.0027

Table S196. Gene #51: 'amp_xq28' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
AMP PEAK 51(XQ28) MUTATED	91	24	0.1 - 110.6 (24.1)
AMP PEAK 51(XQ28) WILD-TYPE	443	57	0.0 - 225.5 (27.9)

Figure S196. Get High-res Image Gene #51: 'amp_xq28' versus Clinical Feature #1: 'Time to Death'

'amp_xq28' versus 'YEARS_TO_BIRTH'

P value = 0.0511 (Wilcoxon-test), Q value = 0.11

Table S197. Gene #51: 'amp_xq28' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
AMP PEAK 51(XQ28) MUTATED	91	66.1 (12.1)
AMP PEAK 51(XQ28) WILD-TYPE	443	63.6 (11.0)

Figure S197. Get High-res Image Gene #51: 'amp_xq28' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'amp_xq28' versus 'HISTOLOGICAL_TYPE'

P value = 0.00032 (Fisher's exact test), Q value = 0.0012

Table S198. Gene #51: 'amp_xq28' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
AMP PEAK 51(XQ28) MUTATED	54	4	34
AMP PEAK 51(XQ28) WILD-TYPE	347	18	79

Figure S198. Get High-res Image Gene #51: 'amp_xq28' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_1p36.21' versus 'Time to Death'

P value = 0.0169 (logrank test), Q value = 0.039

Table S199. Gene #52: 'del_1p36.21' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 1(1P36.21) MUTATED	71	18	0.4 - 149.6 (26.1)
DEL PEAK 1(1P36.21) WILD-TYPE	463	63	0.0 - 225.5 (27.4)

Figure S199. Get High-res Image Gene #52: 'del_1p36.21' versus Clinical Feature #1: 'Time to Death'

'del_1p36.21' versus 'YEARS_TO_BIRTH'

P value = 0.000121 (Wilcoxon-test), Q value = 0.00051

Table S200. Gene #52: 'del_1p36.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 1(1P36.21) MUTATED	71	69.1 (10.3)
DEL PEAK 1(1P36.21) WILD-TYPE	463	63.2 (11.1)

Figure S200. Get High-res Image Gene #52: 'del_1p36.21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_1p36.21' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S201. Gene #52: 'del_1p36.21' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 1(1P36.21) MUTATED	28	5	38
DEL PEAK 1(1P36.21) WILD-TYPE	373	17	75

Figure S201. Get High-res Image Gene #52: 'del_1p36.21' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_1p36.11' versus 'Time to Death'

P value = 5.81e-05 (logrank test), Q value = 0.00027

Table S202. Gene #53: 'del_1p36.11' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 2(1P36.11) MUTATED	81	23	0.4 - 149.6 (25.9)
DEL PEAK 2(1P36.11) WILD-TYPE	453	58	0.0 - 225.5 (27.9)

Figure S202. Get High-res Image Gene #53: 'del_1p36.11' versus Clinical Feature #1: 'Time to Death'

'del_1p36.11' versus 'YEARS_TO_BIRTH'

P value = 7.6e-05 (Wilcoxon-test), Q value = 0.00035

Table S203. Gene #53: 'del_1p36.11' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 2(1P36.11) MUTATED	82	68.6 (9.5)
DEL PEAK 2(1P36.11) WILD-TYPE	452	63.1 (11.3)

Figure S203. Get High-res Image Gene #53: 'del_1p36.11' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_1p36.11' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S204. Gene #53: 'del_1p36.11' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 2(1P36.11) MUTATED	27	5	50
DEL PEAK 2(1P36.11) WILD-TYPE	374	17	63

Figure S204. Get High-res Image Gene #53: 'del_1p36.11' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_1p36.11' versus 'RESIDUAL_TUMOR'

P value = 0.0579 (Fisher's exact test), Q value = 0.12

Table S205. Gene #53: 'del_1p36.11' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 2(1P36.11) MUTATED	53	7	5	5
DEL PEAK 2(1P36.11) WILD-TYPE	317	15	12	32

Figure S205. Get High-res Image Gene #53: 'del_1p36.11' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_2p25.3' versus 'Time to Death'

P value = 0.0148 (logrank test), Q value = 0.035

Table S206. Gene #54: 'del_2p25.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 3(2P25.3) MUTATED	25	7	0.6 - 125.4 (20.8)
DEL PEAK 3(2P25.3) WILD-TYPE	509	74	0.0 - 225.5 (27.9)

Figure S206. Get High-res Image Gene #54: 'del_2p25.3' versus Clinical Feature #1: 'Time to Death'

'del_2p25.3' versus 'YEARS_TO_BIRTH'

P value = 0.0671 (Wilcoxon-test), Q value = 0.13

Table S207. Gene #54: 'del_2p25.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 3(2P25.3) MUTATED	26	66.8 (7.9)
DEL PEAK 3(2P25.3) WILD-TYPE	508	63.8 (11.3)

Figure S207. Get High-res Image Gene #54: 'del_2p25.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_2p25.3' versus 'RADIATION_THERAPY'

P value = 0.13 (Fisher's exact test), Q value = 0.23

Table S208. Gene #54: 'del_2p25.3' versus Clinical Feature #3: 'RADIATION_THERAPY'

nPatients	NO	YES
ALL	284	218
DEL PEAK 3(2P25.3) MUTATED	16	6
DEL PEAK 3(2P25.3) WILD-TYPE	268	212

Figure S208. Get High-res Image Gene #54: 'del_2p25.3' versus Clinical Feature #3: 'RADIATION_THERAPY'

'del_2p25.3' versus 'HISTOLOGICAL_TYPE'

P value = 0.0101 (Fisher's exact test), Q value = 0.025

Table S209. Gene #54: 'del_2p25.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 3(2P25.3) MUTATED	13	2	11
DEL PEAK 3(2P25.3) WILD-TYPE	388	20	102

Figure S209. Get High-res Image Gene #54: 'del_2p25.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_2q22.1' versus 'Time to Death'

P value = 2.27e-10 (logrank test), Q value = 5.3e-08

Table S210. Gene #55: 'del_2q22.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 4(2Q22.1) MUTATED	47	20	0.6 - 125.4 (20.2)
DEL PEAK 4(2Q22.1) WILD-TYPE	487	61	0.0 - 225.5 (28.1)

Figure S210. Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #1: 'Time to Death'

'del_2q22.1' versus 'YEARS_TO_BIRTH'

P value = 0.00603 (Wilcoxon-test), Q value = 0.016

Table S211. Gene #55: 'del_2q22.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 4(2Q22.1) MUTATED	47	67.9 (9.3)
DEL PEAK 4(2Q22.1) WILD-TYPE	487	63.6 (11.3)

Figure S211. Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_2q22.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S212. Gene #55: 'del_2q22.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 4(2Q22.1) MUTATED	18	2	27
DEL PEAK 4(2Q22.1) WILD-TYPE	383	20	86

Figure S212. Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_2q22.1' versus 'RESIDUAL_TUMOR'

P value = 0.00071 (Fisher's exact test), Q value = 0.0024

Table S213. Gene #55: 'del_2q22.1' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 4(2Q22.1) MUTATED	24	2	5	8
DEL PEAK 4(2Q22.1) WILD-TYPE	346	20	12	29

Figure S213. Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_2q22.1' versus 'RACE'

P value = 0.112 (Fisher's exact test), Q value = 0.2

Table S214. Gene #55: 'del_2q22.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 4(2Q22.1) MUTATED	0	1	16	1	26
DEL PEAK 4(2Q22.1) WILD-TYPE	4	19	90	8	342

Figure S214. Get High-res Image Gene #55: 'del_2q22.1' versus Clinical Feature #6: 'RACE'

'del_2q37.3' versus 'Time to Death'

P value = 0.0814 (logrank test), Q value = 0.16

Table S215. Gene #56: 'del_2q37.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 5(2Q37.3) MUTATED	51	12	0.6 - 118.2 (23.9)
DEL PEAK 5(2Q37.3) WILD-TYPE	483	69	0.0 - 225.5 (27.6)

Figure S215. Get High-res Image Gene #56: 'del_2q37.3' versus Clinical Feature #1: 'Time to Death'

'del_2q37.3' versus 'YEARS_TO_BIRTH'

P value = 0.00233 (Wilcoxon-test), Q value = 0.0069

Table S216. Gene #56: 'del_2q37.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 5(2Q37.3) MUTATED	52	68.2 (8.4)
DEL PEAK 5(2Q37.3) WILD-TYPE	482	63.5 (11.4)

Figure S216. Get High-res Image Gene #56: 'del_2q37.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_2q37.3' versus 'HISTOLOGICAL_TYPE'

P value = 5e-05 (Fisher's exact test), Q value = 0.00024

Table S217. Gene #56: 'del_2q37.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 5(2Q37.3) MUTATED	26	2	24
DEL PEAK 5(2Q37.3) WILD-TYPE	375	20	89

Figure S217. Get High-res Image Gene #56: 'del_2q37.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_2q37.3' versus 'RESIDUAL_TUMOR'

P value = 0.0515 (Fisher's exact test), Q value = 0.11

Table S218. Gene #56: 'del_2q37.3' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 5(2Q37.3) MUTATED	32	2	3	8
DEL PEAK 5(2Q37.3) WILD-TYPE	338	20	14	29

Figure S218. Get High-res Image Gene #56: 'del_2q37.3' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_3p14.2' versus 'Time to Death'

P value = 0.0217 (logrank test), Q value = 0.049

Table S219. Gene #57: 'del_3p14.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 6(3P14.2) MUTATED	78	17	0.1 - 125.4 (22.5)
DEL PEAK 6(3P14.2) WILD-TYPE	456	64	0.0 - 225.5 (28.2)

Figure S219. Get High-res Image Gene #57: 'del_3p14.2' versus Clinical Feature #1: 'Time to Death'

'del_3p14.2' versus 'YEARS_TO_BIRTH'

P value = 0.000663 (Wilcoxon-test), Q value = 0.0023

Table S220. Gene #57: 'del_3p14.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 6(3P14.2) MUTATED	78	67.7 (8.2)
DEL PEAK 6(3P14.2) WILD-TYPE	456	63.4 (11.5)

Figure S220. Get High-res Image Gene #57: 'del_3p14.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_3p14.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S221. Gene #57: 'del_3p14.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 6(3P14.2) MUTATED	29	6	44
DEL PEAK 6(3P14.2) WILD-TYPE	372	16	69

Figure S221. Get High-res Image Gene #57: 'del_3p14.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_3p14.2' versus 'RACE'

P value = 0.0365 (Fisher's exact test), Q value = 0.079

Table S222. Gene #57: 'del_3p14.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 6(3P14.2) MUTATED	0	1	25	0	47
DEL PEAK 6(3P14.2) WILD-TYPE	4	19	81	9	321

Figure S222. Get High-res Image Gene #57: 'del_3p14.2' versus Clinical Feature #6: 'RACE'

'del_3p14.2' versus 'ETHNICITY'

P value = 0.141 (Fisher's exact test), Q value = 0.24

Table S223. Gene #57: 'del_3p14.2' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	15	372
DEL PEAK 6(3P14.2) MUTATED	0	58
DEL PEAK 6(3P14.2) WILD-TYPE	15	314

Figure S223. Get High-res Image Gene #57: 'del_3p14.2' versus Clinical Feature #7: 'ETHNICITY'

'del_3q13.31' versus 'YEARS_TO_BIRTH'

P value = 0.000552 (Wilcoxon-test), Q value = 0.002

Table S224. Gene #58: 'del_3q13.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 7(3Q13.31) MUTATED	43	69.1 (10.2)
DEL PEAK 7(3Q13.31) WILD-TYPE	491	63.5 (11.2)

Figure S224. Get High-res Image Gene #58: 'del_3q13.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_3q13.31' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S225. Gene #58: 'del_3q13.31' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 7(3Q13.31) MUTATED	18	3	22
DEL PEAK 7(3Q13.31) WILD-TYPE	383	19	91

Figure S225. Get High-res Image Gene #58: 'del_3q13.31' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_4p16.3' versus 'Time to Death'

P value = 0.0108 (logrank test), Q value = 0.027

Table S226. Gene #59: 'del_4p16.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 8(4P16.3) MUTATED	92	21	0.0 - 149.6 (22.3)
DEL PEAK 8(4P16.3) WILD-TYPE	442	60	0.1 - 225.5 (28.6)

Figure S226. Get High-res Image Gene #59: 'del_4p16.3' versus Clinical Feature #1: 'Time to Death'

'del_4p16.3' versus 'YEARS_TO_BIRTH'

P value = 9.76e-05 (Wilcoxon-test), Q value = 0.00043

Table S227. Gene #59: 'del_4p16.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 8(4P16.3) MUTATED	93	68.1 (9.1)
DEL PEAK 8(4P16.3) WILD-TYPE	441	63.1 (11.4)

Figure S227. Get High-res Image Gene #59: 'del_4p16.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_4p16.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S228. Gene #59: 'del_4p16.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 8(4P16.3) MUTATED	31	6	56
DEL PEAK 8(4P16.3) WILD-TYPE	370	16	57

Figure S228. Get High-res Image Gene #59: 'del_4p16.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_4p15.2' versus 'Time to Death'

P value = 0.00164 (logrank test), Q value = 0.005

Table S229. Gene #60: 'del_4p15.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 9(4P15.2) MUTATED	96	24	0.0 - 149.6 (23.5)
DEL PEAK 9(4P15.2) WILD-TYPE	438	57	0.1 - 225.5 (28.3)

Figure S229. Get High-res Image Gene #60: 'del_4p15.2' versus Clinical Feature #1: 'Time to Death'

'del_4p15.2' versus 'YEARS_TO_BIRTH'

P value = 3.76e-05 (Wilcoxon-test), Q value = 2e-04

Table S230. Gene #60: 'del_4p15.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 9(4P15.2) MUTATED	97	68.2 (9.1)
DEL PEAK 9(4P15.2) WILD-TYPE	437	63.1 (11.4)

Figure S230. Get High-res Image Gene #60: 'del_4p15.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_4p15.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S231. Gene #60: 'del_4p15.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 9(4P15.2) MUTATED	33	6	58
DEL PEAK 9(4P15.2) WILD-TYPE	368	16	55

Figure S231. Get High-res Image Gene #60: 'del_4p15.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_4q22.1' versus 'Time to Death'

P value = 0.000148 (logrank test), Q value = 0.00061

Table S232. Gene #61: 'del_4q22.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 10(4Q22.1) MUTATED	104	29	0.0 - 149.6 (26.0)
DEL PEAK 10(4Q22.1) WILD-TYPE	430	52	0.1 - 225.5 (27.8)

Figure S232. Get High-res Image Gene #61: 'del_4q22.1' versus Clinical Feature #1: 'Time to Death'

'del_4q22.1' versus 'YEARS_TO_BIRTH'

P value = 5.72e-06 (Wilcoxon-test), Q value = 5.5e-05

Table S233. Gene #61: 'del_4q22.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 10(4Q22.1) MUTATED	105	68.3 (8.9)
DEL PEAK 10(4Q22.1) WILD-TYPE	429	62.9 (11.5)

Figure S233. Get High-res Image Gene #61: 'del_4q22.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_4q22.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S234. Gene #61: 'del_4q22.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 10(4Q22.1) MUTATED	32	6	67
DEL PEAK 10(4Q22.1) WILD-TYPE	369	16	46

Figure S234. Get High-res Image Gene #61: 'del_4q22.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_4q22.1' versus 'RESIDUAL_TUMOR'

P value = 0.0508 (Fisher's exact test), Q value = 0.11

Table S235. Gene #61: 'del_4q22.1' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 10(4Q22.1) MUTATED	64	6	7	9
DEL PEAK 10(4Q22.1) WILD-TYPE	306	16	10	28

Figure S235. Get High-res Image Gene #61: 'del_4q22.1' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_4q34.3' versus 'Time to Death'

P value = 0.000579 (logrank test), Q value = 0.002

Table S236. Gene #62: 'del_4q34.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 11(4Q34.3) MUTATED	128	31	0.0 - 149.6 (25.8)
DEL PEAK 11(4Q34.3) WILD-TYPE	406	50	0.1 - 225.5 (28.1)

Figure S236. Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #1: 'Time to Death'

'del_4q34.3' versus 'YEARS_TO_BIRTH'

P value = 3.28e-07 (Wilcoxon-test), Q value = 1.3e-05

Table S237. Gene #62: 'del_4q34.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 11(4Q34.3) MUTATED	129	68.1 (9.8)
DEL PEAK 11(4Q34.3) WILD-TYPE	405	62.7 (11.3)

Figure S237. Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_4q34.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S238. Gene #62: 'del_4q34.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 11(4Q34.3) MUTATED	44	8	77
DEL PEAK 11(4Q34.3) WILD-TYPE	357	14	36

Figure S238. Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_4q34.3' versus 'RESIDUAL_TUMOR'

P value = 0.133 (Fisher's exact test), Q value = 0.24

Table S239. Gene #62: 'del_4q34.3' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 11(4Q34.3) MUTATED	82	6	8	8
DEL PEAK 11(4Q34.3) WILD-TYPE	288	16	9	29

Figure S239. Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_4q34.3' versus 'RACE'

P value = 0.0305 (Fisher's exact test), Q value = 0.067

Table S240. Gene #62: 'del_4q34.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 11(4Q34.3) MUTATED	0	4	37	3	77
DEL PEAK 11(4Q34.3) WILD-TYPE	4	16	69	6	291

Figure S240. Get High-res Image Gene #62: 'del_4q34.3' versus Clinical Feature #6: 'RACE'

'del_5q12.1' versus 'Time to Death'

P value = 0.00106 (logrank test), Q value = 0.0034

Table S241. Gene #63: 'del_5q12.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 12(5Q12.1) MUTATED	110	27	0.1 - 149.6 (24.8)
DEL PEAK 12(5Q12.1) WILD-TYPE	424	54	0.0 - 225.5 (28.0)

Figure S241. Get High-res Image Gene #63: 'del_5q12.1' versus Clinical Feature #1: 'Time to Death'

'del_5q12.1' versus 'YEARS_TO_BIRTH'

P value = 3.34e-06 (Wilcoxon-test), Q value = 5.5e-05

Table S242. Gene #63: 'del_5q12.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 12(5Q12.1) MUTATED	110	68.0 (9.7)
DEL PEAK 12(5Q12.1) WILD-TYPE	424	63.0 (11.3)

Figure S242. Get High-res Image Gene #63: 'del_5q12.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_5q12.1' versus 'RADIATION_THERAPY'

P value = 0.092 (Fisher's exact test), Q value = 0.17

Table S243. Gene #63: 'del_5q12.1' versus Clinical Feature #3: 'RADIATION_THERAPY'

nPatients	NO	YES
ALL	284	218
DEL PEAK 12(5Q12.1) MUTATED	49	51
DEL PEAK 12(5Q12.1) WILD-TYPE	235	167

Figure S243. Get High-res Image Gene #63: 'del_5q12.1' versus Clinical Feature #3: 'RADIATION_THERAPY'

'del_5q12.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S244. Gene #63: 'del_5q12.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 12(5Q12.1) MUTATED	37	4	70
DEL PEAK 12(5Q12.1) WILD-TYPE	364	18	43

Figure S244. Get High-res Image Gene #63: 'del_5q12.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_5q12.1' versus 'RACE'

P value = 0.134 (Fisher's exact test), Q value = 0.24

Table S245. Gene #63: 'del_5q12.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 12(5Q12.1) MUTATED	0	3	29	3	65
DEL PEAK 12(5Q12.1) WILD-TYPE	4	17	77	6	303

Figure S245. Get High-res Image Gene #63: 'del_5q12.1' versus Clinical Feature #6: 'RACE'

'del_5q12.1' versus 'ETHNICITY'

P value = 0.102 (Fisher's exact test), Q value = 0.19

Table S246. Gene #63: 'del_5q12.1' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	15	372
DEL PEAK 12(5Q12.1) MUTATED	6	77
DEL PEAK 12(5Q12.1) WILD-TYPE	9	295

Figure S246. Get High-res Image Gene #63: 'del_5q12.1' versus Clinical Feature #7: 'ETHNICITY'

'del_6q26' versus 'Time to Death'

P value = 0.137 (logrank test), Q value = 0.24

Table S247. Gene #64: 'del_6q26' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 13(6Q26) MUTATED	45	11	0.6 - 149.6 (29.4)
DEL PEAK 13(6Q26) WILD-TYPE	489	70	0.0 - 225.5 (27.3)

Figure S247. Get High-res Image Gene #64: 'del_6q26' versus Clinical Feature #1: 'Time to Death'

'del_6q26' versus 'YEARS_TO_BIRTH'

P value = 0.0076 (Wilcoxon-test), Q value = 0.02

Table S248. Gene #64: 'del_6q26' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 13(6Q26) MUTATED	46	68.6 (11.1)
DEL PEAK 13(6Q26) WILD-TYPE	488	63.6 (11.1)

Figure S248. Get High-res Image Gene #64: 'del_6q26' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_6q26' versus 'RADIATION_THERAPY'

P value = 0.0684 (Fisher's exact test), Q value = 0.14

Table S249. Gene #64: 'del_6q26' versus Clinical Feature #3: 'RADIATION_THERAPY'

nPatients	NO	YES
ALL	284	218
DEL PEAK 13(6Q26) MUTATED	17	23
DEL PEAK 13(6Q26) WILD-TYPE	267	195

Figure S249. Get High-res Image Gene #64: 'del_6q26' versus Clinical Feature #3: 'RADIATION_THERAPY'

'del_6q26' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S250. Gene #64: 'del_6q26' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 13(6Q26) MUTATED	13	3	30
DEL PEAK 13(6Q26) WILD-TYPE	388	19	83

Figure S250. Get High-res Image Gene #64: 'del_6q26' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_7p22.3' versus 'Time to Death'

P value = 0.00038 (logrank test), Q value = 0.0014

Table S251. Gene #65: 'del_7p22.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 14(7P22.3) MUTATED	71	21	0.6 - 110.6 (27.9)
DEL PEAK 14(7P22.3) WILD-TYPE	463	60	0.0 - 225.5 (27.4)

Figure S251. Get High-res Image Gene #65: 'del_7p22.3' versus Clinical Feature #1: 'Time to Death'

'del_7p22.3' versus 'YEARS_TO_BIRTH'

P value = 3.85e-05 (Wilcoxon-test), Q value = 2e-04

Table S252. Gene #65: 'del_7p22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 14(7P22.3) MUTATED	71	68.9 (10.2)
DEL PEAK 14(7P22.3) WILD-TYPE	463	63.2 (11.2)

Figure S252. Get High-res Image Gene #65: 'del_7p22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_7p22.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S253. Gene #65: 'del_7p22.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 14(7P22.3) MUTATED	23	5	44
DEL PEAK 14(7P22.3) WILD-TYPE	378	17	69

Figure S253. Get High-res Image Gene #65: 'del_7p22.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_7p22.3' versus 'RESIDUAL_TUMOR'

P value = 0.0934 (Fisher's exact test), Q value = 0.18

Table S254. Gene #65: 'del_7p22.3' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 14(7P22.3) MUTATED	46	4	4	9
DEL PEAK 14(7P22.3) WILD-TYPE	324	18	13	28

Figure S254. Get High-res Image Gene #65: 'del_7p22.3' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_7q11.22' versus 'YEARS_TO_BIRTH'

P value = 3.32e-05 (Wilcoxon-test), Q value = 0.00017

Table S255. Gene #66: 'del_7q11.22' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 15(7Q11.22) MUTATED	41	70.7 (9.9)
DEL PEAK 15(7Q11.22) WILD-TYPE	493	63.4 (11.1)

Figure S255. Get High-res Image Gene #66: 'del_7q11.22' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_7q11.22' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S256. Gene #66: 'del_7q11.22' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 15(7Q11.22) MUTATED	15	2	24
DEL PEAK 15(7Q11.22) WILD-TYPE	386	20	89

Figure S256. Get High-res Image Gene #66: 'del_7q11.22' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_7q31.1' versus 'Time to Death'

P value = 0.011 (logrank test), Q value = 0.027

Table S257. Gene #67: 'del_7q31.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 16(7Q31.1) MUTATED	54	15	0.1 - 118.2 (22.9)
DEL PEAK 16(7Q31.1) WILD-TYPE	480	66	0.0 - 225.5 (27.9)

Figure S257. Get High-res Image Gene #67: 'del_7q31.1' versus Clinical Feature #1: 'Time to Death'

'del_7q31.1' versus 'YEARS_TO_BIRTH'

P value = 7.75e-05 (Wilcoxon-test), Q value = 0.00035

Table S258. Gene #67: 'del_7q31.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 16(7Q31.1) MUTATED	54	69.3 (7.9)
DEL PEAK 16(7Q31.1) WILD-TYPE	480	63.4 (11.4)

Figure S258. Get High-res Image Gene #67: 'del_7q31.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_7q31.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S259. Gene #67: 'del_7q31.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 16(7Q31.1) MUTATED	11	3	40
DEL PEAK 16(7Q31.1) WILD-TYPE	390	19	73

Figure S259. Get High-res Image Gene #67: 'del_7q31.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_7q36.1' versus 'Time to Death'

P value = 0.0014 (logrank test), Q value = 0.0044

Table S260. Gene #68: 'del_7q36.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 17(7Q36.1) MUTATED	63	20	1.8 - 125.4 (26.1)
DEL PEAK 17(7Q36.1) WILD-TYPE	471	61	0.0 - 225.5 (27.4)

Figure S260. Get High-res Image Gene #68: 'del_7q36.1' versus Clinical Feature #1: 'Time to Death'

'del_7q36.1' versus 'YEARS_TO_BIRTH'

P value = 4.8e-07 (Wilcoxon-test), Q value = 1.7e-05

Table S261. Gene #68: 'del_7q36.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 17(7Q36.1) MUTATED	63	70.5 (8.5)
DEL PEAK 17(7Q36.1) WILD-TYPE	471	63.1 (11.2)

Figure S261. Get High-res Image Gene #68: 'del_7q36.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_7q36.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S262. Gene #68: 'del_7q36.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 17(7Q36.1) MUTATED	13	4	46
DEL PEAK 17(7Q36.1) WILD-TYPE	388	18	67

Figure S262. Get High-res Image Gene #68: 'del_7q36.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_8p23.2' versus 'Time to Death'

P value = 5.01e-05 (logrank test), Q value = 0.00024

Table S263. Gene #69: 'del_8p23.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 18(8P23.2) MUTATED	116	31	0.3 - 225.5 (23.8)
DEL PEAK 18(8P23.2) WILD-TYPE	418	50	0.0 - 185.8 (28.4)

Figure S263. Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #1: 'Time to Death'

'del_8p23.2' versus 'YEARS_TO_BIRTH'

P value = 7.95e-06 (Wilcoxon-test), Q value = 5.5e-05

Table S264. Gene #69: 'del_8p23.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 18(8P23.2) MUTATED	116	67.7 (9.3)
DEL PEAK 18(8P23.2) WILD-TYPE	418	63.0 (11.5)

Figure S264. Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_8p23.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S265. Gene #69: 'del_8p23.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 18(8P23.2) MUTATED	35	6	77
DEL PEAK 18(8P23.2) WILD-TYPE	366	16	36

Figure S265. Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_8p23.2' versus 'RESIDUAL_TUMOR'

P value = 0.0505 (Fisher's exact test), Q value = 0.11

Table S266. Gene #69: 'del_8p23.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 18(8P23.2) MUTATED	71	5	7	12
DEL PEAK 18(8P23.2) WILD-TYPE	299	17	10	25

Figure S266. Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_8p23.2' versus 'RACE'

P value = 0.0086 (Fisher's exact test), Q value = 0.022

Table S267. Gene #69: 'del_8p23.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 18(8P23.2) MUTATED	1	2	36	2	68
DEL PEAK 18(8P23.2) WILD-TYPE	3	18	70	7	300

Figure S267. Get High-res Image Gene #69: 'del_8p23.2' versus Clinical Feature #6: 'RACE'

'del_8p21.2' versus 'Time to Death'

P value = 0.00106 (logrank test), Q value = 0.0034

Table S268. Gene #70: 'del_8p21.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 19(8P21.2) MUTATED	115	29	0.3 - 225.5 (25.1)
DEL PEAK 19(8P21.2) WILD-TYPE	419	52	0.0 - 185.8 (28.3)

Figure S268. Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #1: 'Time to Death'

'del_8p21.2' versus 'YEARS_TO_BIRTH'

P value = 8.97e-07 (Wilcoxon-test), Q value = 2.9e-05

Table S269. Gene #70: 'del_8p21.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 19(8P21.2) MUTATED	115	68.2 (9.1)
DEL PEAK 19(8P21.2) WILD-TYPE	419	62.8 (11.4)

Figure S269. Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_8p21.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S270. Gene #70: 'del_8p21.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 19(8P21.2) MUTATED	27	7	82
DEL PEAK 19(8P21.2) WILD-TYPE	374	15	31

Figure S270. Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_8p21.2' versus 'RESIDUAL_TUMOR'

P value = 0.135 (Fisher's exact test), Q value = 0.24

Table S271. Gene #70: 'del_8p21.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 19(8P21.2) MUTATED	72	5	7	10
DEL PEAK 19(8P21.2) WILD-TYPE	298	17	10	27

Figure S271. Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_8p21.2' versus 'RACE'

P value = 0.0109 (Fisher's exact test), Q value = 0.027

Table S272. Gene #70: 'del_8p21.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 19(8P21.2) MUTATED	1	2	35	2	66
DEL PEAK 19(8P21.2) WILD-TYPE	3	18	71	7	302

Figure S272. Get High-res Image Gene #70: 'del_8p21.2' versus Clinical Feature #6: 'RACE'

'del_9p23' versus 'Time to Death'

P value = 0.0083 (logrank test), Q value = 0.022

Table S273. Gene #71: 'del_9p23' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 20(9P23) MUTATED	79	20	0.3 - 149.6 (25.9)
DEL PEAK 20(9P23) WILD-TYPE	455	61	0.0 - 225.5 (28.0)

Figure S273. Get High-res Image Gene #71: 'del_9p23' versus Clinical Feature #1: 'Time to Death'

'del_9p23' versus 'YEARS_TO_BIRTH'

P value = 0.0011 (Wilcoxon-test), Q value = 0.0035

Table S274. Gene #71: 'del_9p23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 20(9P23) MUTATED	79	67.7 (9.2)
DEL PEAK 20(9P23) WILD-TYPE	455	63.3 (11.4)

Figure S274. Get High-res Image Gene #71: 'del_9p23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_9p23' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S275. Gene #71: 'del_9p23' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 20(9P23) MUTATED	30	4	45
DEL PEAK 20(9P23) WILD-TYPE	371	18	68

Figure S275. Get High-res Image Gene #71: 'del_9p23' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_9q21.2' versus 'Time to Death'

P value = 8.73e-05 (logrank test), Q value = 0.00039

Table S276. Gene #72: 'del_9q21.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 21(9Q21.2) MUTATED	129	34	0.0 - 136.6 (25.5)
DEL PEAK 21(9Q21.2) WILD-TYPE	405	47	0.1 - 225.5 (28.3)

Figure S276. Get High-res Image Gene #72: 'del_9q21.2' versus Clinical Feature #1: 'Time to Death'

'del_9q21.2' versus 'YEARS_TO_BIRTH'

P value = 3.59e-10 (Wilcoxon-test), Q value = 6.3e-08

Table S277. Gene #72: 'del_9q21.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 21(9Q21.2) MUTATED	128	69.1 (9.0)
DEL PEAK 21(9Q21.2) WILD-TYPE	406	62.4 (11.3)

Figure S277. Get High-res Image Gene #72: 'del_9q21.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_9q21.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S278. Gene #72: 'del_9q21.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 21(9Q21.2) MUTATED	51	10	68
DEL PEAK 21(9Q21.2) WILD-TYPE	350	12	45

Figure S278. Get High-res Image Gene #72: 'del_9q21.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_9q21.2' versus 'RESIDUAL_TUMOR'

P value = 0.0872 (Fisher's exact test), Q value = 0.17

Table S279. Gene #72: 'del_9q21.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 21(9Q21.2) MUTATED	80	5	7	13
DEL PEAK 21(9Q21.2) WILD-TYPE	290	17	10	24

Figure S279. Get High-res Image Gene #72: 'del_9q21.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_9q21.2' versus 'RACE'

P value = 0.0558 (Fisher's exact test), Q value = 0.11

Table S280. Gene #72: 'del_9q21.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 21(9Q21.2) MUTATED	1	1	34	2	83
DEL PEAK 21(9Q21.2) WILD-TYPE	3	19	72	7	285

Figure S280. Get High-res Image Gene #72: 'del_9q21.2' versus Clinical Feature #6: 'RACE'

'del_9q34.2' versus 'Time to Death'

P value = 3.31e-05 (logrank test), Q value = 0.00017

Table S281. Gene #73: 'del_9q34.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 22(9Q34.2) MUTATED	130	36	0.0 - 136.6 (27.2)
DEL PEAK 22(9Q34.2) WILD-TYPE	404	45	0.1 - 225.5 (27.4)

Figure S281. Get High-res Image Gene #73: 'del_9q34.2' versus Clinical Feature #1: 'Time to Death'

'del_9q34.2' versus 'YEARS_TO_BIRTH'

P value = 1.7e-08 (Wilcoxon-test), Q value = 8.2e-07

Table S282. Gene #73: 'del_9q34.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 22(9Q34.2) MUTATED	130	68.6 (8.6)
DEL PEAK 22(9Q34.2) WILD-TYPE	404	62.5 (11.5)

Figure S282. Get High-res Image Gene #73: 'del_9q34.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_9q34.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S283. Gene #73: 'del_9q34.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 22(9Q34.2) MUTATED	54	10	67
DEL PEAK 22(9Q34.2) WILD-TYPE	347	12	46

Figure S283. Get High-res Image Gene #73: 'del_9q34.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_9q34.2' versus 'RESIDUAL_TUMOR'

P value = 0.0973 (Fisher's exact test), Q value = 0.18

Table S284. Gene #73: 'del_9q34.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 22(9Q34.2) MUTATED	80	5	6	14
DEL PEAK 22(9Q34.2) WILD-TYPE	290	17	11	23

Figure S284. Get High-res Image Gene #73: 'del_9q34.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_10q23.31' versus 'Time to Death'

P value = 0.000945 (logrank test), Q value = 0.0031

Table S285. Gene #74: 'del_10q23.31' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 23(10Q23.31) MUTATED	76	20	0.3 - 125.4 (22.5)
DEL PEAK 23(10Q23.31) WILD-TYPE	458	61	0.0 - 225.5 (28.6)

Figure S285. Get High-res Image Gene #74: 'del_10q23.31' versus Clinical Feature #1: 'Time to Death'

'del_10q23.31' versus 'YEARS_TO_BIRTH'

P value = 0.000291 (Wilcoxon-test), Q value = 0.0011

Table S286. Gene #74: 'del_10q23.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 23(10Q23.31) MUTATED	76	68.0 (9.8)
DEL PEAK 23(10Q23.31) WILD-TYPE	458	63.3 (11.3)

Figure S286. Get High-res Image Gene #74: 'del_10q23.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_10q23.31' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S287. Gene #74: 'del_10q23.31' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 23(10Q23.31) MUTATED	32	6	39
DEL PEAK 23(10Q23.31) WILD-TYPE	369	16	74

Figure S287. Get High-res Image Gene #74: 'del_10q23.31' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_11p15.5' versus 'Time to Death'

P value = 0.00177 (logrank test), Q value = 0.0054

Table S288. Gene #75: 'del_11p15.5' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 24(11P15.5) MUTATED	104	25	0.1 - 149.6 (22.8)
DEL PEAK 24(11P15.5) WILD-TYPE	430	56	0.0 - 225.5 (28.3)

Figure S288. Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #1: 'Time to Death'

'del_11p15.5' versus 'YEARS_TO_BIRTH'

P value = 4.71e-06 (Wilcoxon-test), Q value = 5.5e-05

Table S289. Gene #75: 'del_11p15.5' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 24(11P15.5) MUTATED	104	68.3 (9.0)
DEL PEAK 24(11P15.5) WILD-TYPE	430	63.0 (11.4)

Figure S289. Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_11p15.5' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S290. Gene #75: 'del_11p15.5' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 24(11P15.5) MUTATED	38	6	61
DEL PEAK 24(11P15.5) WILD-TYPE	363	16	52

Figure S290. Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_11p15.5' versus 'RESIDUAL_TUMOR'

P value = 0.05 (Fisher's exact test), Q value = 0.1

Table S291. Gene #75: 'del_11p15.5' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 24(11P15.5) MUTATED	64	3	7	10
DEL PEAK 24(11P15.5) WILD-TYPE	306	19	10	27

Figure S291. Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_11p15.5' versus 'RACE'

P value = 0.0595 (Fisher's exact test), Q value = 0.12

Table S292. Gene #75: 'del_11p15.5' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 24(11P15.5) MUTATED	1	3	31	1	62
DEL PEAK 24(11P15.5) WILD-TYPE	3	17	75	8	306

Figure S292. Get High-res Image Gene #75: 'del_11p15.5' versus Clinical Feature #6: 'RACE'

'del_11q14.1' versus 'Time to Death'

P value = 0.0298 (logrank test), Q value = 0.066

Table S293. Gene #76: 'del_11q14.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 25(11Q14.1) MUTATED	70	15	0.3 - 136.6 (22.3)
DEL PEAK 25(11Q14.1) WILD-TYPE	464	66	0.0 - 225.5 (28.4)

Figure S293. Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #1: 'Time to Death'

'del_11q14.1' versus 'YEARS_TO_BIRTH'

P value = 0.000255 (Wilcoxon-test), Q value = 0.00099

Table S294. Gene #76: 'del_11q14.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 25(11Q14.1) MUTATED	70	68.6 (8.8)
DEL PEAK 25(11Q14.1) WILD-TYPE	464	63.3 (11.4)

Figure S294. Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_11q14.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S295. Gene #76: 'del_11q14.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 25(11Q14.1) MUTATED	21	6	43
DEL PEAK 25(11Q14.1) WILD-TYPE	380	16	70

Figure S295. Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_11q14.1' versus 'RACE'

P value = 0.115 (Fisher's exact test), Q value = 0.21

Table S296. Gene #76: 'del_11q14.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 25(11Q14.1) MUTATED	1	2	21	0	42
DEL PEAK 25(11Q14.1) WILD-TYPE	3	18	85	9	326

Figure S296. Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #6: 'RACE'

'del_11q14.1' versus 'ETHNICITY'

P value = 0.0148 (Fisher's exact test), Q value = 0.035

Table S297. Gene #76: 'del_11q14.1' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	15	372
DEL PEAK 25(11Q14.1) MUTATED	6	52
DEL PEAK 25(11Q14.1) WILD-TYPE	9	320

Figure S297. Get High-res Image Gene #76: 'del_11q14.1' versus Clinical Feature #7: 'ETHNICITY'

'del_11q25' versus 'Time to Death'

P value = 0.000456 (logrank test), Q value = 0.0017

Table S298. Gene #77: 'del_11q25' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 26(11Q25) MUTATED	92	23	0.3 - 136.6 (22.5)
DEL PEAK 26(11Q25) WILD-TYPE	442	58	0.0 - 225.5 (28.4)

Figure S298. Get High-res Image Gene #77: 'del_11q25' versus Clinical Feature #1: 'Time to Death'

'del_11q25' versus 'YEARS_TO_BIRTH'

P value = 0.000222 (Wilcoxon-test), Q value = 0.00087

Table S299. Gene #77: 'del_11q25' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 26(11Q25) MUTATED	92	67.6 (9.7)
DEL PEAK 26(11Q25) WILD-TYPE	442	63.3 (11.3)

Figure S299. Get High-res Image Gene #77: 'del_11q25' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_11q25' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S300. Gene #77: 'del_11q25' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 26(11Q25) MUTATED	32	6	54
DEL PEAK 26(11Q25) WILD-TYPE	369	16	59

Figure S300. Get High-res Image Gene #77: 'del_11q25' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_11q25' versus 'RACE'

P value = 0.127 (Fisher's exact test), Q value = 0.23

Table S301. Gene #77: 'del_11q25' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 26(11Q25) MUTATED	1	2	26	1	54
DEL PEAK 26(11Q25) WILD-TYPE	3	18	80	8	314

Figure S301. Get High-res Image Gene #77: 'del_11q25' versus Clinical Feature #6: 'RACE'

'del_12q23.1' versus 'Time to Death'

P value = 0.00111 (logrank test), Q value = 0.0035

Table S302. Gene #78: 'del_12q23.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 27(12Q23.1) MUTATED	56	16	0.6 - 118.2 (22.9)
DEL PEAK 27(12Q23.1) WILD-TYPE	478	65	0.0 - 225.5 (28.3)

Figure S302. Get High-res Image Gene #78: 'del_12q23.1' versus Clinical Feature #1: 'Time to Death'

'del_12q23.1' versus 'YEARS_TO_BIRTH'

P value = 0.00192 (Wilcoxon-test), Q value = 0.0058

Table S303. Gene #78: 'del_12q23.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 27(12Q23.1) MUTATED	56	68.2 (9.6)
DEL PEAK 27(12Q23.1) WILD-TYPE	478	63.5 (11.3)

Figure S303. Get High-res Image Gene #78: 'del_12q23.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_12q23.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S304. Gene #78: 'del_12q23.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 27(12Q23.1) MUTATED	14	3	39
DEL PEAK 27(12Q23.1) WILD-TYPE	387	19	74

Figure S304. Get High-res Image Gene #78: 'del_12q23.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_12q23.1' versus 'RESIDUAL_TUMOR'

P value = 0.0105 (Fisher's exact test), Q value = 0.026

Table S305. Gene #78: 'del_12q23.1' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 27(12Q23.1) MUTATED	34	1	4	9
DEL PEAK 27(12Q23.1) WILD-TYPE	336	21	13	28

Figure S305. Get High-res Image Gene #78: 'del_12q23.1' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_12q23.1' versus 'RACE'

P value = 0.0741 (Fisher's exact test), Q value = 0.15

Table S306. Gene #78: 'del_12q23.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 27(12Q23.1) MUTATED	1	0	16	0	31
DEL PEAK 27(12Q23.1) WILD-TYPE	3	20	90	9	337

Figure S306. Get High-res Image Gene #78: 'del_12q23.1' versus Clinical Feature #6: 'RACE'

'del_12q24.33' versus 'Time to Death'

P value = 0.00445 (logrank test), Q value = 0.012

Table S307. Gene #79: 'del_12q24.33' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 28(12Q24.33) MUTATED	65	16	0.1 - 118.2 (22.0)
DEL PEAK 28(12Q24.33) WILD-TYPE	469	65	0.0 - 225.5 (28.3)

Figure S307. Get High-res Image Gene #79: 'del_12q24.33' versus Clinical Feature #1: 'Time to Death'

'del_12q24.33' versus 'YEARS_TO_BIRTH'

P value = 4.04e-05 (Wilcoxon-test), Q value = 2e-04

Table S308. Gene #79: 'del_12q24.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 28(12Q24.33) MUTATED	65	69.0 (8.7)
DEL PEAK 28(12Q24.33) WILD-TYPE	469	63.3 (11.3)

Figure S308. Get High-res Image Gene #79: 'del_12q24.33' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_12q24.33' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S309. Gene #79: 'del_12q24.33' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 28(12Q24.33) MUTATED	19	2	44
DEL PEAK 28(12Q24.33) WILD-TYPE	382	20	69

Figure S309. Get High-res Image Gene #79: 'del_12q24.33' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_12q24.33' versus 'RESIDUAL_TUMOR'

P value = 0.0189 (Fisher's exact test), Q value = 0.043

Table S310. Gene #79: 'del_12q24.33' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 28(12Q24.33) MUTATED	40	2	5	9
DEL PEAK 28(12Q24.33) WILD-TYPE	330	20	12	28

Figure S310. Get High-res Image Gene #79: 'del_12q24.33' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_13q11' versus 'Time to Death'

P value = 0.000943 (logrank test), Q value = 0.0031

Table S311. Gene #80: 'del_13q11' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 29(13Q11) MUTATED	96	25	0.1 - 149.6 (22.3)
DEL PEAK 29(13Q11) WILD-TYPE	438	56	0.0 - 225.5 (28.4)

Figure S311. Get High-res Image Gene #80: 'del_13q11' versus Clinical Feature #1: 'Time to Death'

'del_13q11' versus 'YEARS_TO_BIRTH'

P value = 0.00113 (Wilcoxon-test), Q value = 0.0036

Table S312. Gene #80: 'del_13q11' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 29(13Q11) MUTATED	96	67.1 (9.6)
DEL PEAK 29(13Q11) WILD-TYPE	438	63.3 (11.4)

Figure S312. Get High-res Image Gene #80: 'del_13q11' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_13q11' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S313. Gene #80: 'del_13q11' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 29(13Q11) MUTATED	40	6	51
DEL PEAK 29(13Q11) WILD-TYPE	361	16	62

Figure S313. Get High-res Image Gene #80: 'del_13q11' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_13q14.2' versus 'Time to Death'

P value = 0.000985 (logrank test), Q value = 0.0032

Table S314. Gene #81: 'del_13q14.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 30(13Q14.2) MUTATED	105	25	0.1 - 149.6 (22.4)
DEL PEAK 30(13Q14.2) WILD-TYPE	429	56	0.0 - 225.5 (28.6)

Figure S314. Get High-res Image Gene #81: 'del_13q14.2' versus Clinical Feature #1: 'Time to Death'

'del_13q14.2' versus 'YEARS_TO_BIRTH'

P value = 0.000638 (Wilcoxon-test), Q value = 0.0022

Table S315. Gene #81: 'del_13q14.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 30(13Q14.2) MUTATED	105	67.2 (9.6)
DEL PEAK 30(13Q14.2) WILD-TYPE	429	63.2 (11.4)

Figure S315. Get High-res Image Gene #81: 'del_13q14.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_13q14.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S316. Gene #81: 'del_13q14.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 30(13Q14.2) MUTATED	53	7	46
DEL PEAK 30(13Q14.2) WILD-TYPE	348	15	67

Figure S316. Get High-res Image Gene #81: 'del_13q14.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_14q13.1' versus 'Time to Death'

P value = 0.00524 (logrank test), Q value = 0.014

Table S317. Gene #82: 'del_14q13.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 31(14Q13.1) MUTATED	72	16	0.1 - 125.4 (20.3)
DEL PEAK 31(14Q13.1) WILD-TYPE	462	65	0.0 - 225.5 (28.4)

Figure S317. Get High-res Image Gene #82: 'del_14q13.1' versus Clinical Feature #1: 'Time to Death'

'del_14q13.1' versus 'YEARS_TO_BIRTH'

P value = 0.00433 (Wilcoxon-test), Q value = 0.012

Table S318. Gene #82: 'del_14q13.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 31(14Q13.1) MUTATED	72	67.1 (9.8)
DEL PEAK 31(14Q13.1) WILD-TYPE	462	63.5 (11.3)

Figure S318. Get High-res Image Gene #82: 'del_14q13.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_14q13.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S319. Gene #82: 'del_14q13.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 31(14Q13.1) MUTATED	25	5	42
DEL PEAK 31(14Q13.1) WILD-TYPE	376	17	71

Figure S319. Get High-res Image Gene #82: 'del_14q13.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_14q13.1' versus 'RACE'

P value = 0.01 (Fisher's exact test), Q value = 0.025

Table S320. Gene #82: 'del_14q13.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 31(14Q13.1) MUTATED	1	1	25	1	40
DEL PEAK 31(14Q13.1) WILD-TYPE	3	19	81	8	328

Figure S320. Get High-res Image Gene #82: 'del_14q13.1' versus Clinical Feature #6: 'RACE'

'del_14q13.1' versus 'ETHNICITY'

P value = 0.128 (Fisher's exact test), Q value = 0.23

Table S321. Gene #82: 'del_14q13.1' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	15	372
DEL PEAK 31(14Q13.1) MUTATED	4	48
DEL PEAK 31(14Q13.1) WILD-TYPE	11	324

Figure S321. Get High-res Image Gene #82: 'del_14q13.1' versus Clinical Feature #7: 'ETHNICITY'

'del_15q15.1' versus 'Time to Death'

P value = 8.28e-05 (logrank test), Q value = 0.00037

Table S322. Gene #83: 'del_15q15.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 32(15Q15.1) MUTATED	138	34	0.0 - 136.6 (22.9)
DEL PEAK 32(15Q15.1) WILD-TYPE	396	47	0.1 - 225.5 (28.9)

Figure S322. Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #1: 'Time to Death'

'del_15q15.1' versus 'YEARS_TO_BIRTH'

P value = 7.07e-09 (Wilcoxon-test), Q value = 4.5e-07

Table S323. Gene #83: 'del_15q15.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 32(15Q15.1) MUTATED	139	68.5 (9.6)
DEL PEAK 32(15Q15.1) WILD-TYPE	395	62.4 (11.3)

Figure S323. Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_15q15.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S324. Gene #83: 'del_15q15.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 32(15Q15.1) MUTATED	53	10	76
DEL PEAK 32(15Q15.1) WILD-TYPE	348	12	37

Figure S324. Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_15q15.1' versus 'RESIDUAL_TUMOR'

P value = 0.0306 (Fisher's exact test), Q value = 0.067

Table S325. Gene #83: 'del_15q15.1' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 32(15Q15.1) MUTATED	85	7	8	14
DEL PEAK 32(15Q15.1) WILD-TYPE	285	15	9	23

Figure S325. Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_15q15.1' versus 'RACE'

P value = 0.078 (Fisher's exact test), Q value = 0.15

Table S326. Gene #83: 'del_15q15.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 32(15Q15.1) MUTATED	1	2	36	3	86
DEL PEAK 32(15Q15.1) WILD-TYPE	3	18	70	6	282

Figure S326. Get High-res Image Gene #83: 'del_15q15.1' versus Clinical Feature #6: 'RACE'

'del_15q23' versus 'Time to Death'

P value = 0.0181 (logrank test), Q value = 0.042

Table S327. Gene #84: 'del_15q23' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 33(15Q23) MUTATED	115	23	0.0 - 136.6 (21.9)
DEL PEAK 33(15Q23) WILD-TYPE	419	58	0.1 - 225.5 (29.9)

Figure S327. Get High-res Image Gene #84: 'del_15q23' versus Clinical Feature #1: 'Time to Death'

'del_15q23' versus 'YEARS_TO_BIRTH'

P value = 6.34e-06 (Wilcoxon-test), Q value = 5.5e-05

Table S328. Gene #84: 'del_15q23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 33(15Q23) MUTATED	115	67.7 (9.3)
DEL PEAK 33(15Q23) WILD-TYPE	419	63.0 (11.5)

Figure S328. Get High-res Image Gene #84: 'del_15q23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_15q23' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S329. Gene #84: 'del_15q23' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 33(15Q23) MUTATED	38	8	69
DEL PEAK 33(15Q23) WILD-TYPE	363	14	44

Figure S329. Get High-res Image Gene #84: 'del_15q23' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_15q23' versus 'RACE'

P value = 0.0468 (Fisher's exact test), Q value = 0.099

Table S330. Gene #84: 'del_15q23' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 33(15Q23) MUTATED	0	2	33	1	70
DEL PEAK 33(15Q23) WILD-TYPE	4	18	73	8	298

Figure S330. Get High-res Image Gene #84: 'del_15q23' versus Clinical Feature #6: 'RACE'

'del_16p13.3' versus 'Time to Death'

P value = 0.000147 (logrank test), Q value = 0.00061

Table S331. Gene #85: 'del_16p13.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 34(16P13.3) MUTATED	91	24	0.1 - 125.4 (25.5)
DEL PEAK 34(16P13.3) WILD-TYPE	443	57	0.0 - 225.5 (28.3)

Figure S331. Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #1: 'Time to Death'

'del_16p13.3' versus 'YEARS_TO_BIRTH'

P value = 3.51e-06 (Wilcoxon-test), Q value = 5.5e-05

Table S332. Gene #85: 'del_16p13.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 34(16P13.3) MUTATED	92	68.7 (8.6)
DEL PEAK 34(16P13.3) WILD-TYPE	442	63.0 (11.4)

Figure S332. Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_16p13.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S333. Gene #85: 'del_16p13.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 34(16P13.3) MUTATED	27	5	60
DEL PEAK 34(16P13.3) WILD-TYPE	374	17	53

Figure S333. Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_16p13.3' versus 'RESIDUAL_TUMOR'

P value = 0.067 (Fisher's exact test), Q value = 0.13

Table S334. Gene #85: 'del_16p13.3' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 34(16P13.3) MUTATED	54	6	5	9
DEL PEAK 34(16P13.3) WILD-TYPE	316	16	12	28

Figure S334. Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_16p13.3' versus 'RACE'

P value = 0.0611 (Fisher's exact test), Q value = 0.12

Table S335. Gene #85: 'del_16p13.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 34(16P13.3) MUTATED	0	2	28	1	54
DEL PEAK 34(16P13.3) WILD-TYPE	4	18	78	8	314

Figure S335. Get High-res Image Gene #85: 'del_16p13.3' versus Clinical Feature #6: 'RACE'

'del_16q21' versus 'Time to Death'

P value = 0.000561 (logrank test), Q value = 0.002

Table S336. Gene #86: 'del_16q21' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 35(16Q21) MUTATED	152	35	0.1 - 123.7 (25.3)
DEL PEAK 35(16Q21) WILD-TYPE	382	46	0.0 - 225.5 (28.9)

Figure S336. Get High-res Image Gene #86: 'del_16q21' versus Clinical Feature #1: 'Time to Death'

'del_16q21' versus 'YEARS_TO_BIRTH'

P value = 1.24e-08 (Wilcoxon-test), Q value = 6.7e-07

Table S337. Gene #86: 'del_16q21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 35(16Q21) MUTATED	153	68.0 (9.1)
DEL PEAK 35(16Q21) WILD-TYPE	381	62.4 (11.6)

Figure S337. Get High-res Image Gene #86: 'del_16q21' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_16q21' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S338. Gene #86: 'del_16q21' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 35(16Q21) MUTATED	64	9	80
DEL PEAK 35(16Q21) WILD-TYPE	337	13	33

Figure S338. Get High-res Image Gene #86: 'del_16q21' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_16q21' versus 'RACE'

P value = 0.0322 (Fisher's exact test), Q value = 0.07

Table S339. Gene #86: 'del_16q21' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 35(16Q21) MUTATED	1	2	41	2	96
DEL PEAK 35(16Q21) WILD-TYPE	3	18	65	7	272

Figure S339. Get High-res Image Gene #86: 'del_16q21' versus Clinical Feature #6: 'RACE'

'del_16q22.3' versus 'Time to Death'

P value = 0.0092 (logrank test), Q value = 0.024

Table S340. Gene #87: 'del_16q22.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 36(16Q22.3) MUTATED	157	32	0.1 - 123.7 (23.7)
DEL PEAK 36(16Q22.3) WILD-TYPE	377	49	0.0 - 225.5 (29.6)

Figure S340. Get High-res Image Gene #87: 'del_16q22.3' versus Clinical Feature #1: 'Time to Death'

'del_16q22.3' versus 'YEARS_TO_BIRTH'

P value = 2.35e-09 (Wilcoxon-test), Q value = 2.3e-07

Table S341. Gene #87: 'del_16q22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 36(16Q22.3) MUTATED	158	68.1 (9.0)
DEL PEAK 36(16Q22.3) WILD-TYPE	376	62.3 (11.6)

Figure S341. Get High-res Image Gene #87: 'del_16q22.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_16q22.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S342. Gene #87: 'del_16q22.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 36(16Q22.3) MUTATED	69	9	80
DEL PEAK 36(16Q22.3) WILD-TYPE	332	13	33

Figure S342. Get High-res Image Gene #87: 'del_16q22.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_16q22.3' versus 'RESIDUAL_TUMOR'

P value = 0.135 (Fisher's exact test), Q value = 0.24

Table S343. Gene #87: 'del_16q22.3' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 36(16Q22.3) MUTATED	101	9	8	13
DEL PEAK 36(16Q22.3) WILD-TYPE	269	13	9	24

Figure S343. Get High-res Image Gene #87: 'del_16q22.3' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_16q22.3' versus 'RACE'

P value = 0.0468 (Fisher's exact test), Q value = 0.099

Table S344. Gene #87: 'del_16q22.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 36(16Q22.3) MUTATED	1	2	41	2	100
DEL PEAK 36(16Q22.3) WILD-TYPE	3	18	65	7	268

Figure S344. Get High-res Image Gene #87: 'del_16q22.3' versus Clinical Feature #6: 'RACE'

'del_16q23.1' versus 'Time to Death'

P value = 0.000371 (logrank test), Q value = 0.0014

Table S345. Gene #88: 'del_16q23.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 37(16Q23.1) MUTATED	165	37	0.1 - 123.7 (24.1)
DEL PEAK 37(16Q23.1) WILD-TYPE	369	44	0.0 - 225.5 (29.9)

Figure S345. Get High-res Image Gene #88: 'del_16q23.1' versus Clinical Feature #1: 'Time to Death'

'del_16q23.1' versus 'YEARS_TO_BIRTH'

P value = 3.52e-09 (Wilcoxon-test), Q value = 3.1e-07

Table S346. Gene #88: 'del_16q23.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 37(16Q23.1) MUTATED	166	67.8 (9.3)
DEL PEAK 37(16Q23.1) WILD-TYPE	368	62.3 (11.5)

Figure S346. Get High-res Image Gene #88: 'del_16q23.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_16q23.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S347. Gene #88: 'del_16q23.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 37(16Q23.1) MUTATED	71	8	87
DEL PEAK 37(16Q23.1) WILD-TYPE	330	14	26

Figure S347. Get High-res Image Gene #88: 'del_16q23.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_16q23.1' versus 'RESIDUAL_TUMOR'

P value = 0.011 (Fisher's exact test), Q value = 0.027

Table S348. Gene #88: 'del_16q23.1' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 37(16Q23.1) MUTATED	104	8	11	14
DEL PEAK 37(16Q23.1) WILD-TYPE	266	14	6	23

Figure S348. Get High-res Image Gene #88: 'del_16q23.1' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_16q23.1' versus 'RACE'

P value = 0.00673 (Fisher's exact test), Q value = 0.018

Table S349. Gene #88: 'del_16q23.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 37(16Q23.1) MUTATED	1	3	47	2	101
DEL PEAK 37(16Q23.1) WILD-TYPE	3	17	59	7	267

Figure S349. Get High-res Image Gene #88: 'del_16q23.1' versus Clinical Feature #6: 'RACE'

'del_17p13.3' versus 'Time to Death'

P value = 8.93e-06 (logrank test), Q value = 5.5e-05

Table S350. Gene #89: 'del_17p13.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 38(17P13.3) MUTATED	120	32	0.1 - 136.6 (23.5)
DEL PEAK 38(17P13.3) WILD-TYPE	414	49	0.0 - 225.5 (28.3)

Figure S350. Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #1: 'Time to Death'

'del_17p13.3' versus 'YEARS_TO_BIRTH'

P value = 0.000296 (Wilcoxon-test), Q value = 0.0011

Table S351. Gene #89: 'del_17p13.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 38(17P13.3) MUTATED	120	66.9 (9.0)
DEL PEAK 38(17P13.3) WILD-TYPE	414	63.2 (11.6)

Figure S351. Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_17p13.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S352. Gene #89: 'del_17p13.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 38(17P13.3) MUTATED	47	9	65
DEL PEAK 38(17P13.3) WILD-TYPE	354	13	48

Figure S352. Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_17p13.3' versus 'RESIDUAL_TUMOR'

P value = 0.0971 (Fisher's exact test), Q value = 0.18

Table S353. Gene #89: 'del_17p13.3' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 38(17P13.3) MUTATED	73	7	4	13
DEL PEAK 38(17P13.3) WILD-TYPE	297	15	13	24

Figure S353. Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_17p13.3' versus 'RACE'

P value = 0.00488 (Fisher's exact test), Q value = 0.014

Table S354. Gene #89: 'del_17p13.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 38(17P13.3) MUTATED	0	2	37	3	71
DEL PEAK 38(17P13.3) WILD-TYPE	4	18	69	6	297

Figure S354. Get High-res Image Gene #89: 'del_17p13.3' versus Clinical Feature #6: 'RACE'

'del_17p11.2' versus 'Time to Death'

P value = 4.16e-05 (logrank test), Q value = 0.00021

Table S355. Gene #90: 'del_17p11.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 39(17P11.2) MUTATED	126	33	0.1 - 136.6 (23.9)
DEL PEAK 39(17P11.2) WILD-TYPE	408	48	0.0 - 225.5 (28.0)

Figure S355. Get High-res Image Gene #90: 'del_17p11.2' versus Clinical Feature #1: 'Time to Death'

'del_17p11.2' versus 'YEARS_TO_BIRTH'

P value = 1.67e-06 (Wilcoxon-test), Q value = 5.1e-05

Table S356. Gene #90: 'del_17p11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 39(17P11.2) MUTATED	126	67.8 (9.3)
DEL PEAK 39(17P11.2) WILD-TYPE	408	62.8 (11.5)

Figure S356. Get High-res Image Gene #90: 'del_17p11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_17p11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S357. Gene #90: 'del_17p11.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 39(17P11.2) MUTATED	47	9	71
DEL PEAK 39(17P11.2) WILD-TYPE	354	13	42

Figure S357. Get High-res Image Gene #90: 'del_17p11.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_17p11.2' versus 'RACE'

P value = 0.0164 (Fisher's exact test), Q value = 0.038

Table S358. Gene #90: 'del_17p11.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 39(17P11.2) MUTATED	0	2	37	1	78
DEL PEAK 39(17P11.2) WILD-TYPE	4	18	69	8	290

Figure S358. Get High-res Image Gene #90: 'del_17p11.2' versus Clinical Feature #6: 'RACE'

'del_17q11.2' versus 'Time to Death'

P value = 0.00928 (logrank test), Q value = 0.024

Table S359. Gene #91: 'del_17q11.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 40(17Q11.2) MUTATED	103	24	0.1 - 136.6 (25.5)
DEL PEAK 40(17Q11.2) WILD-TYPE	431	57	0.0 - 225.5 (27.6)

Figure S359. Get High-res Image Gene #91: 'del_17q11.2' versus Clinical Feature #1: 'Time to Death'

'del_17q11.2' versus 'YEARS_TO_BIRTH'

P value = 6.1e-07 (Wilcoxon-test), Q value = 2e-05

Table S360. Gene #91: 'del_17q11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 40(17Q11.2) MUTATED	104	68.3 (9.4)
DEL PEAK 40(17Q11.2) WILD-TYPE	430	62.9 (11.3)

Figure S360. Get High-res Image Gene #91: 'del_17q11.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_17q11.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S361. Gene #91: 'del_17q11.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 40(17Q11.2) MUTATED	45	5	54
DEL PEAK 40(17Q11.2) WILD-TYPE	356	17	59

Figure S361. Get High-res Image Gene #91: 'del_17q11.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_17q21.31' versus 'Time to Death'

P value = 0.000181 (logrank test), Q value = 0.00073

Table S362. Gene #92: 'del_17q21.31' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 41(17Q21.31) MUTATED	112	30	0.1 - 136.6 (25.7)
DEL PEAK 41(17Q21.31) WILD-TYPE	422	51	0.0 - 225.5 (27.9)

Figure S362. Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #1: 'Time to Death'

'del_17q21.31' versus 'YEARS_TO_BIRTH'

P value = 5.92e-06 (Wilcoxon-test), Q value = 5.5e-05

Table S363. Gene #92: 'del_17q21.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 41(17Q21.31) MUTATED	112	67.9 (9.7)
DEL PEAK 41(17Q21.31) WILD-TYPE	422	63.0 (11.3)

Figure S363. Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_17q21.31' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S364. Gene #92: 'del_17q21.31' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 41(17Q21.31) MUTATED	46	6	61
DEL PEAK 41(17Q21.31) WILD-TYPE	355	16	52

Figure S364. Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_17q21.31' versus 'RESIDUAL_TUMOR'

P value = 0.0299 (Fisher's exact test), Q value = 0.066

Table S365. Gene #92: 'del_17q21.31' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 41(17Q21.31) MUTATED	68	6	6	13
DEL PEAK 41(17Q21.31) WILD-TYPE	302	16	11	24

Figure S365. Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_17q21.31' versus 'ETHNICITY'

P value = 0.0973 (Fisher's exact test), Q value = 0.18

Table S366. Gene #92: 'del_17q21.31' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	15	372
DEL PEAK 41(17Q21.31) MUTATED	6	75
DEL PEAK 41(17Q21.31) WILD-TYPE	9	297

Figure S366. Get High-res Image Gene #92: 'del_17q21.31' versus Clinical Feature #7: 'ETHNICITY'

'del_18q21.2' versus 'Time to Death'

P value = 0.077 (logrank test), Q value = 0.15

Table S367. Gene #93: 'del_18q21.2' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 42(18Q21.2) MUTATED	89	18	0.1 - 136.6 (23.7)
DEL PEAK 42(18Q21.2) WILD-TYPE	445	63	0.0 - 225.5 (27.9)

Figure S367. Get High-res Image Gene #93: 'del_18q21.2' versus Clinical Feature #1: 'Time to Death'

'del_18q21.2' versus 'YEARS_TO_BIRTH'

P value = 0.000345 (Wilcoxon-test), Q value = 0.0013

Table S368. Gene #93: 'del_18q21.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 42(18Q21.2) MUTATED	90	67.5 (9.8)
DEL PEAK 42(18Q21.2) WILD-TYPE	444	63.3 (11.3)

Figure S368. Get High-res Image Gene #93: 'del_18q21.2' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_18q21.2' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S369. Gene #93: 'del_18q21.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 42(18Q21.2) MUTATED	38	6	46
DEL PEAK 42(18Q21.2) WILD-TYPE	363	16	67

Figure S369. Get High-res Image Gene #93: 'del_18q21.2' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_18q21.2' versus 'RESIDUAL_TUMOR'

P value = 0.0714 (Fisher's exact test), Q value = 0.14

Table S370. Gene #93: 'del_18q21.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 42(18Q21.2) MUTATED	51	5	5	9
DEL PEAK 42(18Q21.2) WILD-TYPE	319	17	12	28

Figure S370. Get High-res Image Gene #93: 'del_18q21.2' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_18q21.2' versus 'RACE'

P value = 0.0976 (Fisher's exact test), Q value = 0.18

Table S371. Gene #93: 'del_18q21.2' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 42(18Q21.2) MUTATED	0	2	25	3	54
DEL PEAK 42(18Q21.2) WILD-TYPE	4	18	81	6	314

Figure S371. Get High-res Image Gene #93: 'del_18q21.2' versus Clinical Feature #6: 'RACE'

'del_18q23' versus 'Time to Death'

P value = 0.00053 (logrank test), Q value = 0.0019

Table S372. Gene #94: 'del_18q23' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 43(18Q23) MUTATED	96	24	0.1 - 136.6 (23.7)
DEL PEAK 43(18Q23) WILD-TYPE	438	57	0.0 - 225.5 (27.9)

Figure S372. Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #1: 'Time to Death'

'del_18q23' versus 'YEARS_TO_BIRTH'

P value = 0.000613 (Wilcoxon-test), Q value = 0.0021

Table S373. Gene #94: 'del_18q23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 43(18Q23) MUTATED	96	67.4 (10.1)
DEL PEAK 43(18Q23) WILD-TYPE	438	63.2 (11.3)

Figure S373. Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_18q23' versus 'RADIATION_THERAPY'

P value = 0.143 (Fisher's exact test), Q value = 0.25

Table S374. Gene #94: 'del_18q23' versus Clinical Feature #3: 'RADIATION_THERAPY'

nPatients	NO	YES
ALL	284	218
DEL PEAK 43(18Q23) MUTATED	52	29
DEL PEAK 43(18Q23) WILD-TYPE	232	189

Figure S374. Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #3: 'RADIATION_THERAPY'

'del_18q23' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S375. Gene #94: 'del_18q23' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 43(18Q23) MUTATED	38	6	53
DEL PEAK 43(18Q23) WILD-TYPE	363	16	60

Figure S375. Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_18q23' versus 'RESIDUAL_TUMOR'

P value = 0.0102 (Fisher's exact test), Q value = 0.026

Table S376. Gene #94: 'del_18q23' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 43(18Q23) MUTATED	57	5	8	8
DEL PEAK 43(18Q23) WILD-TYPE	313	17	9	29

Figure S376. Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_18q23' versus 'RACE'

P value = 0.119 (Fisher's exact test), Q value = 0.22

Table S377. Gene #94: 'del_18q23' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 43(18Q23) MUTATED	1	2	26	3	59
DEL PEAK 43(18Q23) WILD-TYPE	3	18	80	6	309

Figure S377. Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #6: 'RACE'

'del_18q23' versus 'ETHNICITY'

P value = 0.0415 (Fisher's exact test), Q value = 0.089

Table S378. Gene #94: 'del_18q23' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	15	372
DEL PEAK 43(18Q23) MUTATED	6	66
DEL PEAK 43(18Q23) WILD-TYPE	9	306

Figure S378. Get High-res Image Gene #94: 'del_18q23' versus Clinical Feature #7: 'ETHNICITY'

'del_19p13.3' versus 'Time to Death'

P value = 3.5e-07 (logrank test), Q value = 1.3e-05

Table S379. Gene #95: 'del_19p13.3' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 44(19P13.3) MUTATED	152	42	0.1 - 136.6 (24.0)
DEL PEAK 44(19P13.3) WILD-TYPE	382	39	0.0 - 225.5 (28.3)

Figure S379. Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #1: 'Time to Death'

'del_19p13.3' versus 'YEARS_TO_BIRTH'

P value = 8.99e-11 (Wilcoxon-test), Q value = 3.1e-08

Table S380. Gene #95: 'del_19p13.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 44(19P13.3) MUTATED	152	68.6 (8.6)
DEL PEAK 44(19P13.3) WILD-TYPE	382	62.2 (11.6)

Figure S380. Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_19p13.3' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S381. Gene #95: 'del_19p13.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 44(19P13.3) MUTATED	45	9	99
DEL PEAK 44(19P13.3) WILD-TYPE	356	13	14

Figure S381. Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_19p13.3' versus 'RESIDUAL_TUMOR'

P value = 0.0087 (Fisher's exact test), Q value = 0.022

Table S382. Gene #95: 'del_19p13.3' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 44(19P13.3) MUTATED	92	9	9	15
DEL PEAK 44(19P13.3) WILD-TYPE	278	13	8	22

Figure S382. Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_19p13.3' versus 'RACE'

P value = 6e-04 (Fisher's exact test), Q value = 0.0021

Table S383. Gene #95: 'del_19p13.3' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 44(19P13.3) MUTATED	1	2	47	3	92
DEL PEAK 44(19P13.3) WILD-TYPE	3	18	59	6	276

Figure S383. Get High-res Image Gene #95: 'del_19p13.3' versus Clinical Feature #6: 'RACE'

'del_19p12' versus 'YEARS_TO_BIRTH'

P value = 0.00728 (Wilcoxon-test), Q value = 0.019

Table S384. Gene #96: 'del_19p12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 45(19P12) MUTATED	57	67.5 (9.9)
DEL PEAK 45(19P12) WILD-TYPE	477	63.6 (11.3)

Figure S384. Get High-res Image Gene #96: 'del_19p12' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_19p12' versus 'RADIATION_THERAPY'

P value = 0.139 (Fisher's exact test), Q value = 0.24

Table S385. Gene #96: 'del_19p12' versus Clinical Feature #3: 'RADIATION_THERAPY'

nPatients	NO	YES
ALL	284	218
DEL PEAK 45(19P12) MUTATED	24	28
DEL PEAK 45(19P12) WILD-TYPE	260	190

Figure S385. Get High-res Image Gene #96: 'del_19p12' versus Clinical Feature #3: 'RADIATION_THERAPY'

'del_19p12' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S386. Gene #96: 'del_19p12' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 45(19P12) MUTATED	21	5	32
DEL PEAK 45(19P12) WILD-TYPE	380	17	81

Figure S386. Get High-res Image Gene #96: 'del_19p12' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_19p12' versus 'RESIDUAL_TUMOR'

P value = 0.0812 (Fisher's exact test), Q value = 0.16

Table S387. Gene #96: 'del_19p12' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 45(19P12) MUTATED	33	3	2	8
DEL PEAK 45(19P12) WILD-TYPE	337	19	15	29

Figure S387. Get High-res Image Gene #96: 'del_19p12' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_19q13.43' versus 'Time to Death'

P value = 0.000694 (logrank test), Q value = 0.0023

Table S388. Gene #97: 'del_19q13.43' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 46(19Q13.43) MUTATED	66	19	0.1 - 125.4 (23.8)
DEL PEAK 46(19Q13.43) WILD-TYPE	468	62	0.0 - 225.5 (27.9)

Figure S388. Get High-res Image Gene #97: 'del_19q13.43' versus Clinical Feature #1: 'Time to Death'

'del_19q13.43' versus 'YEARS_TO_BIRTH'

P value = 0.000173 (Wilcoxon-test), Q value = 7e-04

Table S389. Gene #97: 'del_19q13.43' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 46(19Q13.43) MUTATED	66	68.4 (9.8)
DEL PEAK 46(19Q13.43) WILD-TYPE	468	63.4 (11.3)

Figure S389. Get High-res Image Gene #97: 'del_19q13.43' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_19q13.43' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S390. Gene #97: 'del_19q13.43' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 46(19Q13.43) MUTATED	20	4	43
DEL PEAK 46(19Q13.43) WILD-TYPE	381	18	70

Figure S390. Get High-res Image Gene #97: 'del_19q13.43' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_19q13.43' versus 'RESIDUAL_TUMOR'

P value = 0.0154 (Fisher's exact test), Q value = 0.036

Table S391. Gene #97: 'del_19q13.43' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 46(19Q13.43) MUTATED	37	6	3	8
DEL PEAK 46(19Q13.43) WILD-TYPE	333	16	14	29

Figure S391. Get High-res Image Gene #97: 'del_19q13.43' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_19q13.43' versus 'ETHNICITY'

P value = 0.101 (Fisher's exact test), Q value = 0.19

Table S392. Gene #97: 'del_19q13.43' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	15	372
DEL PEAK 46(19Q13.43) MUTATED	4	44
DEL PEAK 46(19Q13.43) WILD-TYPE	11	328

Figure S392. Get High-res Image Gene #97: 'del_19q13.43' versus Clinical Feature #7: 'ETHNICITY'

'del_20p12.1' versus 'Time to Death'

P value = 6.68e-05 (logrank test), Q value = 0.00031

Table S393. Gene #98: 'del_20p12.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 47(20P12.1) MUTATED	36	14	0.3 - 149.6 (27.8)
DEL PEAK 47(20P12.1) WILD-TYPE	498	67	0.0 - 225.5 (27.3)

Figure S393. Get High-res Image Gene #98: 'del_20p12.1' versus Clinical Feature #1: 'Time to Death'

'del_20p12.1' versus 'HISTOLOGICAL_TYPE'

P value = 5e-05 (Fisher's exact test), Q value = 0.00024

Table S394. Gene #98: 'del_20p12.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 47(20P12.1) MUTATED	16	2	18
DEL PEAK 47(20P12.1) WILD-TYPE	385	20	95

Figure S394. Get High-res Image Gene #98: 'del_20p12.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_20p12.1' versus 'ETHNICITY'

P value = 0.11 (Fisher's exact test), Q value = 0.2

Table S395. Gene #98: 'del_20p12.1' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	15	372
DEL PEAK 47(20P12.1) MUTATED	3	28
DEL PEAK 47(20P12.1) WILD-TYPE	12	344

Figure S395. Get High-res Image Gene #98: 'del_20p12.1' versus Clinical Feature #7: 'ETHNICITY'

'del_22q13.32' versus 'Time to Death'

P value = 0.000171 (logrank test), Q value = 0.00069

Table S396. Gene #99: 'del_22q13.32' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 48(22Q13.32) MUTATED	139	33	0.1 - 136.6 (22.6)
DEL PEAK 48(22Q13.32) WILD-TYPE	395	48	0.0 - 225.5 (28.9)

Figure S396. Get High-res Image Gene #99: 'del_22q13.32' versus Clinical Feature #1: 'Time to Death'

'del_22q13.32' versus 'YEARS_TO_BIRTH'

P value = 4.77e-08 (Wilcoxon-test), Q value = 2e-06

Table S397. Gene #99: 'del_22q13.32' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 48(22Q13.32) MUTATED	139	68.4 (9.5)
DEL PEAK 48(22Q13.32) WILD-TYPE	395	62.4 (11.3)

Figure S397. Get High-res Image Gene #99: 'del_22q13.32' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_22q13.32' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S398. Gene #99: 'del_22q13.32' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 48(22Q13.32) MUTATED	56	11	73
DEL PEAK 48(22Q13.32) WILD-TYPE	345	11	40

Figure S398. Get High-res Image Gene #99: 'del_22q13.32' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_22q13.32' versus 'RESIDUAL_TUMOR'

P value = 0.141 (Fisher's exact test), Q value = 0.24

Table S399. Gene #99: 'del_22q13.32' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 48(22Q13.32) MUTATED	90	6	6	15
DEL PEAK 48(22Q13.32) WILD-TYPE	280	16	11	22

Figure S399. Get High-res Image Gene #99: 'del_22q13.32' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_22q13.32' versus 'RACE'

P value = 0.0234 (Fisher's exact test), Q value = 0.053

Table S400. Gene #99: 'del_22q13.32' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 48(22Q13.32) MUTATED	1	1	38	2	91
DEL PEAK 48(22Q13.32) WILD-TYPE	3	19	68	7	277

Figure S400. Get High-res Image Gene #99: 'del_22q13.32' versus Clinical Feature #6: 'RACE'

'del_22q13.32' versus 'ETHNICITY'

P value = 0.138 (Fisher's exact test), Q value = 0.24

Table S401. Gene #99: 'del_22q13.32' versus Clinical Feature #7: 'ETHNICITY'

nPatients	HISPANIC OR LATINO	NOT HISPANIC OR LATINO
ALL	15	372
DEL PEAK 48(22Q13.32) MUTATED	7	101
DEL PEAK 48(22Q13.32) WILD-TYPE	8	271

Figure S401. Get High-res Image Gene #99: 'del_22q13.32' versus Clinical Feature #7: 'ETHNICITY'

'del_xp21.1' versus 'Time to Death'

P value = 7.05e-06 (logrank test), Q value = 5.5e-05

Table S402. Gene #100: 'del_xp21.1' versus Clinical Feature #1: 'Time to Death'

	nPatients	nDeath	Duration Range (Median), Month
ALL	534	81	0.0 - 225.5 (27.4)
DEL PEAK 49(XP21.1) MUTATED	86	26	0.3 - 118.2 (22.2)
DEL PEAK 49(XP21.1) WILD-TYPE	448	55	0.0 - 225.5 (28.6)

Figure S402. Get High-res Image Gene #100: 'del_xp21.1' versus Clinical Feature #1: 'Time to Death'

'del_xp21.1' versus 'YEARS_TO_BIRTH'

P value = 0.000153 (Wilcoxon-test), Q value = 0.00063

Table S403. Gene #100: 'del_xp21.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

	nPatients	Mean (Std.Dev)
ALL	534	64.0 (11.2)
DEL PEAK 49(XP21.1) MUTATED	86	68.0 (9.2)
DEL PEAK 49(XP21.1) WILD-TYPE	448	63.2 (11.4)

Figure S403. Get High-res Image Gene #100: 'del_xp21.1' versus Clinical Feature #2: 'YEARS_TO_BIRTH'

'del_xp21.1' versus 'HISTOLOGICAL_TYPE'

P value = 1e-05 (Fisher's exact test), Q value = 5.5e-05

Table S404. Gene #100: 'del_xp21.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

nPatients	ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA	MIXED SEROUS AND ENDOMETRIOID	SEROUS ENDOMETRIAL ADENOCARCINOMA
ALL	401	22	113
DEL PEAK 49(XP21.1) MUTATED	32	4	51
DEL PEAK 49(XP21.1) WILD-TYPE	369	18	62

Figure S404. Get High-res Image Gene #100: 'del_xp21.1' versus Clinical Feature #4: 'HISTOLOGICAL_TYPE'

'del_xp21.1' versus 'RESIDUAL_TUMOR'

P value = 0.123 (Fisher's exact test), Q value = 0.22

Table S405. Gene #100: 'del_xp21.1' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

nPatients	R0	R1	R2	RX
ALL	370	22	17	37
DEL PEAK 49(XP21.1) MUTATED	55	2	6	7
DEL PEAK 49(XP21.1) WILD-TYPE	315	20	11	30

Figure S405. Get High-res Image Gene #100: 'del_xp21.1' versus Clinical Feature #5: 'RESIDUAL_TUMOR'

'del_xp21.1' versus 'RACE'

P value = 0.00535 (Fisher's exact test), Q value = 0.015

Table S406. Gene #100: 'del_xp21.1' versus Clinical Feature #6: 'RACE'

nPatients	AMERICAN INDIAN OR ALASKA NATIVE	ASIAN	BLACK OR AFRICAN AMERICAN	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	WHITE
ALL	4	20	106	9	368
DEL PEAK 49(XP21.1) MUTATED	1	1	29	1	48
DEL PEAK 49(XP21.1) WILD-TYPE	3	19	77	8	320

Figure S406. Get High-res Image Gene #100: 'del_xp21.1' versus Clinical Feature #6: 'RACE'

Methods & Data

Input

Copy number data file = all_lesions.txt from GISTIC pipeline
Processed Copy number data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_Correlate_Genomic_Events_Preprocess/UCEC-TP/19782701/transformed.cor.cli.txt
Clinical data file = /xchip/cga/gdac-prod/tcga-gdac/jobResults/Append_Data/UCEC-TP/19775642/UCEC-TP.merged_data.txt
Number of patients = 536
Number of significantly focal cnvs = 100
Number of selected clinical features = 7
Exclude genes that fewer than K tumors have mutations, K = 3

Survival analysis

For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R

Fisher's exact test

For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.

References

[1] Bland and Altman, Statistics notes: The logrank test, BMJ 328(7447):1073 (2004)

[2] Fisher, R.A., On the interpretation of chi-square from contingency tables, and the calculation of P, Journal of the Royal Statistical Society 85(1):87-94 (1922)

[3] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)

Made with Nozzle